Medicine – Hormone Effects on the Kidney

The kidneys are both targets and producers of hormones. Hormones regulate renal handling of sodium, water, potassium, hydrogen ions, calcium and phosphate, while the kidneys themselves produce or activate substances such as renin, erythropoietin and calcitriol.

The major hormones shown in the original table are aldosterone, atrial natriuretic peptide, catecholamines, calcitriol, erythropoietin, prostaglandins, parathyroid hormone, vasopressin and renin.

1. Aldosterone

Aldosterone is a mineralocorticoid produced by the:

Zona glomerulosa of the adrenal cortex.

Its major renal actions occur mainly in the:

Late distal nephron and collecting duct.

Renal Effects of Aldosterone

Aldosterone increases:

Sodium reabsorption.

It also increases:

Potassium secretion

and

Hydrogen ion secretion.

Therefore:

ALDOSTERONE → ↑ Na⁺ REABSORPTION + ↑ K⁺ SECRETION + ↑ H⁺ SECRETION.

Water tends to follow retained sodium, helping expand:

Extracellular fluid volume.

Clinical Importance

Excess aldosterone can produce:

Hypertension.

Hypokalaemia.

Metabolic alkalosis.

Conversely, aldosterone deficiency or resistance may produce:

Hyperkalaemia

and

Metabolic acidosis.

2. Atrial Natriuretic Peptide

Atrial natriuretic peptide – ANP is released mainly from atrial cardiac myocytes in response to:

Atrial stretch and increased intravascular volume.

Its overall purpose is to reduce:

Sodium and fluid overload.

Renal Effects of ANP

ANP promotes:

Natriuresis → increased sodium excretion.

It also promotes:

Diuresis → increased water excretion.

Therefore:

ANP → ↑ Na⁺ EXCRETION + ↑ H₂O EXCRETION.

Additional Actions

ANP also opposes sodium-retaining systems by suppressing:

Renin.

Aldosterone.

It therefore acts broadly against the:

Renin–angiotensin–aldosterone system.

3. Catecholamines

Catecholamines such as:

Noradrenaline

and

Adrenaline

affect renal haemodynamics and renin release.

Sympathetic stimulation of:

β₁ receptors on juxtaglomerular cells

increases:

Renin secretion.

Therefore:

SYMPATHETIC β₁ STIMULATION → ↑ RENIN.

Additional Renal Effects

Strong sympathetic activation also causes:

Renal vasoconstriction

and can reduce:

Renal blood flow.

This becomes particularly important during:

Haemorrhage, severe hypotension and physiological stress.

4. 1,25-Dihydroxyvitamin D

1,25-Dihydroxyvitamin D, also called:

Calcitriol,

is the biologically active form of vitamin D.

The kidney converts:

25-hydroxyvitamin D

into:

1,25-dihydroxyvitamin D

through the enzyme:

1α-hydroxylase.

Main Effects of Calcitriol

The most important action of calcitriol is actually outside the kidney:

It increases intestinal calcium and phosphate absorption.

It also participates in calcium and phosphate homeostasis and has renal effects on mineral handling.

Therefore, the original table’s statement that calcitriol simply “increases tubular calcium reabsorption” is incomplete.

The major high-yield concept is:

KIDNEY ACTIVATES VITAMIN D → CALCITRIOL → ↑ INTESTINAL Ca²⁺ AND PHOSPHATE ABSORPTION.

5. Kidney Disease and Calcitriol

In advanced CKD, functioning renal mass and renal 1α-hydroxylase activity decline.

Therefore:

↓ Calcitriol production

↓

↓ Intestinal calcium absorption

↓

Tendency toward hypocalcaemic stimulation

↓

↑ PTH

↓

Secondary hyperparathyroidism.

This is an important mechanism in:

CKD-mineral and bone disorder.

6. Erythropoietin

Erythropoietin – EPO is produced predominantly by specialised:

Renal interstitial cells

in response to reduced tissue oxygen availability.

Effect of Erythropoietin

EPO travels to the:

Bone marrow

where it stimulates:

Erythropoiesis.

This increases production of:

Red blood cells.

Therefore:

RENAL HYPOXIA → ↑ EPO → BONE MARROW → ↑ RBC PRODUCTION.

7. Erythropoietin and CKD

In chronic kidney disease, the kidneys lose their ability to produce an appropriate amount of EPO.

This contributes to:

Anaemia of CKD.

The typical anaemia is:

Normocytic and normochromic.

Therefore:

CKD → RELATIVE EPO DEFICIENCY → ANAEMIA.

8. Prostaglandins

The kidneys produce prostaglandins, particularly:

PGE₂

and

PGI₂ – prostacyclin.

These have important local effects on:

Renal vascular tone.

Renal Effects of Prostaglandins

Renal prostaglandins promote:

Vasodilation, particularly helping preserve afferent arteriolar blood flow under physiological stress.

They therefore help maintain:

Renal blood flow

and

GFR

when vasoconstrictor systems are activated.

They can also facilitate:

Renin release.

9. Prostaglandins and NSAIDs

This explains an important clinical effect of:

NSAIDs.

NSAIDs inhibit:

Cyclo-oxygenase – COX

↓

reduce:

Prostaglandin synthesis

↓

reduce protective:

Afferent arteriolar vasodilation

↓

may decrease:

Renal blood flow and GFR.

Clinical Consequence

This is particularly dangerous in patients whose renal perfusion is already compromised, such as those with:

Dehydration.

Heart failure.

Advanced CKD.

Cirrhosis.

Therefore:

NSAID → ↓ PROSTAGLANDINS → AFFERENT CONSTRICTION → ↓ GFR → AKI RISK.

10. Parathyroid Hormone

Parathyroid hormone – PTH is produced by the:

Parathyroid glands

and has several important renal effects.

Its overall role is to increase:

Serum calcium

while reducing:

Serum phosphate.

11. PTH and Calcium

PTH increases renal:

Calcium reabsorption, particularly in the distal nephron.

Therefore:

Less calcium is lost in urine.

This contributes to the rise in:

Serum calcium.

12. PTH and Phosphate

PTH decreases proximal tubular:

Phosphate reabsorption.

Therefore more phosphate is excreted in urine.

This is called:

Phosphaturia.

Therefore:

PTH → ↑ PHOSPHATE EXCRETION.

13. PTH and Bicarbonate

PTH also decreases proximal tubular bicarbonate reabsorption to some extent.

Therefore it can increase:

Bicarbonate excretion.

This effect is less clinically emphasized than its actions on calcium and phosphate.

14. PTH and Vitamin D

PTH stimulates renal:

1α-hydroxylase.

This increases conversion of:

25-hydroxyvitamin D

to

1,25-dihydroxyvitamin D – calcitriol.

Therefore:

PTH → ↑ CALCITRIOL SYNTHESIS.

15. Overall Renal Effects of PTH

The easiest pattern to remember is:

PTH SAVES CALCIUM.

PTH WASTES PHOSPHATE.

PTH ACTIVATES VITAMIN D.

Therefore:

PTH → ↑ Ca²⁺ reabsorption + ↑ phosphate excretion + ↑ calcitriol synthesis.

16. Vasopressin

Vasopressin, also called:

Antidiuretic hormone – ADH,

is synthesised in the:

Hypothalamus

and released from the:

Posterior pituitary.

Its major renal function is regulation of:

Water balance.

17. Renal Effects of ADH

ADH binds to:

V₂ receptors

on principal cells in the collecting ducts.

This activates intracellular signalling that inserts:

Aquaporin-2 water channels

into the apical membrane.

Result

More water is reabsorbed from the collecting duct.

Therefore:

Urine volume decreases

and

Urine becomes more concentrated.

This is:

Antidiuresis.

Therefore:

ADH → V₂ → AQUAPORIN-2 → ↑ WATER REABSORPTION → ↓ URINE VOLUME.

18. ADH Deficiency

If ADH is deficient, as in:

Central diabetes insipidus,

the collecting ducts cannot appropriately concentrate urine.

This produces:

Large volumes of dilute urine.

Polyuria.

Polydipsia.

19. Excess ADH

Excessive ADH activity occurs in:

SIADH.

This causes excessive water retention and produces:

Dilutional hyponatraemia.

Therefore:

EXCESS ADH → WATER RETENTION → HYPONATRAEMIA.

20. Renin

Renin is an enzyme produced by:

Juxtaglomerular cells of the kidney.

Its secretion increases when the kidney detects reduced effective circulating volume or reduced renal perfusion.

21. Stimuli for Renin Release

Important stimuli include:

Reduced renal perfusion pressure.

Reduced NaCl delivery to the macula densa.

β₁ sympathetic stimulation.

Therefore:

LOW PERFUSION + LOW NaCl DELIVERY + β₁ STIMULATION → ↑ RENIN.

22. Renin–Angiotensin–Aldosterone System

Renin converts:

Angiotensinogen

to

Angiotensin I.

ACE then converts:

Angiotensin I

to

Angiotensin II.

Angiotensin II

Angiotensin II causes:

Vasoconstriction.

It preferentially constricts the:

Efferent arteriole at physiologically relevant levels.

It also stimulates:

Aldosterone release.

ADH release.

Thirst.

Proximal sodium reabsorption.

23. Overall RAAS Effect

The overall purpose of RAAS is to defend:

Blood pressure

and

Effective circulating volume.

The sequence is:

↓ Renal perfusion

↓

↑ Renin

↓

↑ Angiotensin II

↓

Vasoconstriction + ↑ aldosterone

↓

↑ Na⁺ and water retention

↓

↑ Blood pressure and circulating volume.

24. Important Correction – Renin

The original table states:

“Renin – autoregulation of renal blood flow.”

This is an oversimplification.

Renin is primarily the initiating enzyme of the:

Renin–angiotensin–aldosterone system.

It participates in the response to reduced renal perfusion, but classic renal autoregulation itself depends importantly on:

Myogenic mechanisms

and

Tubuloglomerular feedback.

Therefore the better high-yield statement is:

RENIN → ACTIVATES RAAS → REGULATES BLOOD PRESSURE, SODIUM BALANCE AND EFFECTIVE CIRCULATING VOLUME.

25. Aldosterone – Note Form

Source:

Adrenal cortex, zona glomerulosa.

Kidney effect:

↑ Na⁺ reabsorption.

↑ K⁺ secretion.

↑ H⁺ secretion.

Memory point:

ALDOSTERONE SAVES Na⁺, LOSES K⁺ AND H⁺.

26. ANP – Note Form

Source:

Atrial myocardium.

Stimulus:

Atrial stretch/volume expansion.

Kidney effect:

↑ Na⁺ excretion.

↑ Water excretion.

Suppresses renin/aldosterone.

Memory point:

ANP GETS RID OF SALT AND WATER.

27. Catecholamines – Note Form

Main renal effect:

β₁ sympathetic stimulation of juxtaglomerular cells.

↓

↑ Renin secretion.

Strong sympathetic activity also:

↓ Renal blood flow through vasoconstriction.

28. Calcitriol – Note Form

1,25-dihydroxyvitamin D = calcitriol.

Kidney activates vitamin D through:

1α-hydroxylase.

Major effect:

↑ Intestinal calcium and phosphate absorption.

CKD:

↓ Calcitriol → contributes to secondary hyperparathyroidism.

29. Erythropoietin – Note Form

Produced mainly by:

Kidney.

Stimulus:

Tissue hypoxia.

Effect:

↑ Bone marrow erythropoiesis.

CKD:

↓ Appropriate EPO production → anaemia.

30. Prostaglandins – Note Form

Effect:

Maintain renal perfusion through vasodilator effects, particularly at the afferent arteriole.

Can facilitate:

Renin release.

NSAIDs:

↓ Prostaglandins → ↓ afferent vasodilation → ↓ GFR → AKI risk.

31. PTH – Note Form

Renal effects:

↑ Calcium reabsorption.

↑ Phosphate excretion.

↑ Bicarbonate excretion to some degree.

↑ 1α-hydroxylase.

↑ Calcitriol synthesis.

Memory point:

PTH SAVES Ca²⁺, WASTES PHOSPHATE AND ACTIVATES VITAMIN D.

32. ADH – Note Form

ADH = vasopressin.

Acts on:

V₂ receptors in collecting ducts.

Causes:

Aquaporin-2 insertion.

Therefore:

↑ Water reabsorption.

↓ Urine volume.

↑ Urine concentration.

33. Renin – Note Form

Produced by:

Juxtaglomerular cells.

Stimulated by:

↓ Renal perfusion.

↓ NaCl delivery to macula densa.

β₁ sympathetic activity.

Effect:

Activates RAAS.

↓

↑ Angiotensin II.

↓

↑ Aldosterone.

↓

↑ Sodium/water retention and blood pressure.

Key Clinical Pattern

For rapid recall:

ALDOSTERONE → ↑ Na⁺ REABSORPTION + ↑ K⁺/H⁺ SECRETION.

ANP → ↑ Na⁺ + WATER EXCRETION.

CATECHOLAMINES → β₁ → ↑ RENIN.

CALCITRIOL → ↑ INTESTINAL Ca²⁺ + PHOSPHATE ABSORPTION.

ERYTHROPOIETIN → ↑ RBC PRODUCTION.

PROSTAGLANDINS → HELP MAINTAIN RENAL PERFUSION.

PTH → ↑ Ca²⁺ REABSORPTION + ↑ PHOSPHATE EXCRETION + ↑ CALCITRIOL.

ADH → ↑ WATER REABSORPTION VIA AQUAPORIN-2.

RENIN → ACTIVATES RAAS → ↑ BLOOD PRESSURE + Na⁺/WATER RETENTION.

A useful final memory sequence is:

ADH SAVES WATER.

ALDOSTERONE SAVES SODIUM.

PTH SAVES CALCIUM BUT WASTES PHOSPHATE.

ANP WASTES SODIUM AND WATER.

EPO MAKES RED CELLS.

RENIN ACTIVATES RAAS.

Click here to start customizing

Ophthalmology – Optic Neuritis

Basics

Description

Optic neuritis (ON) is an inflammatory optic neuropathy characterized by acute or subacute visual dysfunction caused by inflammation and demyelination of the optic nerve.

The classic form is:

Typical demyelinating optic neuritis associated with multiple sclerosis (MS)

However, optic neuritis can also occur with:

• MOG antibody-associated disease (MOGAD)
• Aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (AQP4-NMOSD)
• Sarcoidosis
• Systemic autoimmune disease
• Infection
• Postinfectious inflammatory disease

Recognition of these distinct entities is important because their:

• Clinical phenotype
• Prognosis
• Risk of recurrence
• Long-term treatment

differ substantially.

⸻

Typical Demyelinating Optic Neuritis

The classic presentation is:

• Young adult
• Usually female
• Unilateral painful visual loss
• Pain worsened by eye movement
• Dyschromatopsia
• RAPD
• Central or diffuse visual field defect
• Normal-appearing disc in many cases

Visual loss usually evolves over:

Hours to several days

and reaches its nadir within approximately:

1–2 weeks

Spontaneous improvement generally begins within:

2–3 weeks

⸻

Papillitis vs Retrobulbar Optic Neuritis

Papillitis

Inflammation produces:

• Visible optic disc swelling

Retrobulbar Optic Neuritis

The optic disc initially appears:

• Normal

because inflammation is located posterior to the globe.

The classic phrase is:

“The patient sees nothing, and the doctor sees nothing.”

This refers to substantial visual dysfunction despite a normal fundus appearance.

⸻

Epidemiology

Typical demyelinating optic neuritis most commonly affects:

• Young adults
• Approximately 20–50 years of age
• Women more often than men

It is one of the most common causes of:

Acute painful monocular visual loss in a young adult

⸻

Association With Multiple Sclerosis

Optic neuritis may be:

• The first manifestation of MS
• A relapse in established MS
• An isolated clinically isolated syndrome

A substantial proportion of patients with typical ON ultimately develop MS, particularly when baseline brain MRI demonstrates characteristic demyelinating lesions.

⸻

Risk of MS

The strongest predictor of subsequent MS after a typical optic neuritis attack is:

Baseline brain MRI

Risk is substantially higher when characteristic white-matter demyelinating lesions are present.

A normal MRI lowers, but does not eliminate, long-term MS risk.

⸻

Pathophysiology

Typical optic neuritis involves:

Immune-mediated demyelination and axonal injury of the optic nerve

Mechanisms include:

• T-cell-mediated inflammation
• B-cell participation
• Blood–brain barrier disruption
• Myelin injury
• Secondary axonal degeneration

Recovery reflects:

• Resolution of inflammation
• Remyelination
• Neural adaptation

Some permanent retinal ganglion cell and axonal loss commonly remains even when visual acuity returns to normal.

⸻

Etiologic Categories

Important causes include:

Demyelinating

• Multiple sclerosis
• MOGAD
• AQP4-NMOSD

Autoimmune / Inflammatory

• Sarcoidosis
• Systemic lupus erythematosus
• Sjögren syndrome
• Behçet disease
• Granulomatosis with polyangiitis
• IgG4-related disease

Infectious

• Syphilis
• Tuberculosis
• Lyme disease
• Viral infection
• Bartonella
• Other infections depending on exposure and geography

Other

• Postinfectious inflammation
• Postvaccination inflammatory disease
• Optic perineuritis

⸻

History

Typical symptoms include:

• Blurred vision
• Loss of visual acuity
• Reduced color saturation
• Central blur or scotoma
• Pain with eye movement
• Reduced contrast sensitivity

Ask about:

• Previous neurologic symptoms
• Prior episodes of visual loss
• Weakness or sensory disturbance
• Ataxia
• Bladder dysfunction
• Lhermitte phenomenon
• Autoimmune disease
• Infection risk
• Medication or toxin exposure

⸻

Pain With Eye Movement

Pain occurs in the majority of typical MS-associated cases.

It is usually:

• Periocular
• Mild to moderate
• Worse with eye movement

Absence of pain does not exclude ON, but a painless severe optic neuropathy should broaden the differential.

⸻

Visual Acuity

Visual acuity may range from:

• Mildly reduced
• Moderately reduced
• Counting fingers
• Rarely profound loss in typical MS-associated ON

Very severe visual loss, particularly:

• NLP
• Bilateral profound loss

should increase suspicion for:

• AQP4-NMOSD
• MOGAD
• Ischemic optic neuropathy
• Infectious/infiltrative disease

⸻

Color Vision

Dyschromatopsia is a hallmark.

Typical finding:

Color vision loss out of proportion to visual acuity

Patients may describe colors as:

• Washed out
• Less bright
• Less saturated

Red desaturation is common.

⸻

Contrast Sensitivity

Contrast sensitivity is frequently impaired even when Snellen acuity is relatively preserved.

Residual contrast deficits may persist after apparent visual recovery.

⸻

Relative Afferent Pupillary Defect

A RAPD is expected in unilateral or asymmetric optic neuritis.

Absence of RAPD in marked unilateral visual loss should raise concern for:

• Functional visual loss
• Media opacity
• Macular disease
• Symmetric bilateral optic neuropathy

⸻

Visual Field Defects

Typical defects include:

• Central scotoma
• Cecocentral scotoma
• Diffuse depression
• Altitudinal defects
• Arcuate defects

No single visual field pattern is diagnostic.

⸻

Optic Disc Appearance

In typical demyelinating ON:

• Most patients initially have a normal optic disc
• A minority have disc edema

Disc swelling is more common in:

• Children
• MOGAD

Marked disc edema with hemorrhages or macular exudates should prompt consideration of alternative diagnoses.

⸻

Optic Atrophy

Following an attack, the optic nerve may develop:

• Temporal pallor
• Diffuse pallor
• RNFL thinning

usually becoming apparent over subsequent weeks.

⸻

Uhthoff Phenomenon

Uhthoff phenomenon is transient worsening of previously impaired neurologic or visual function with increased body temperature.

Triggers include:

• Exercise
• Fever
• Hot shower
• Hot weather

It reflects impaired conduction in demyelinated axons and does not necessarily indicate recurrent inflammation.

⸻

Pulfrich Phenomenon

Unequal visual conduction between the two eyes can cause moving objects to be perceived along an abnormal three-dimensional trajectory.

A swinging pendulum may appear to move:

Elliptically rather than in a flat plane

This is the Pulfrich phenomenon.

⸻

Typical vs Atypical Optic Neuritis

Recognition of atypical features is critical.

Typical MS-associated ON usually demonstrates:

• Age approximately 20–50 years
• Unilateral disease
• Pain with eye movement
• Moderate visual loss
• Normal or mildly swollen disc
• Improvement beginning within several weeks

⸻

Red Flags for Atypical Optic Neuritis

Features that should prompt broader evaluation include:

• Age <10 or >50 years
• Bilateral simultaneous disease
• Recurrent attacks
• Profound visual loss
• Lack of pain
• Marked optic disc swelling
• Disc hemorrhages
• Macular star
• Severe vitritis
• Retinal inflammation
• Progressive deterioration beyond 2 weeks
• No meaningful recovery
• Steroid dependence
• Chiasmal involvement
• Longitudinally extensive optic nerve enhancement

These findings raise concern for:

• MOGAD
• AQP4-NMOSD
• Sarcoidosis
• Infection
• Infiltrative disease
• Optic perineuritis

⸻

MOG Antibody-Associated Optic Neuritis

MOGAD optic neuritis commonly demonstrates:

• Bilateral disease
• Recurrent attacks
• Severe optic disc edema
• Peripapillary hemorrhage
• Long-segment optic nerve enhancement
• Anterior optic nerve involvement
• Perineural enhancement

Visual loss may initially be severe, but recovery is often relatively good.

⸻

AQP4-NMOSD Optic Neuritis

AQP4-associated ON commonly demonstrates:

• Severe visual loss
• Bilateral or sequential attacks
• Poorer visual recovery
• Posterior optic nerve involvement
• Chiasmal involvement
• Longitudinally extensive enhancement

It has a high risk of:

Permanent visual disability after recurrent attacks

Therefore early recognition is important.

⸻

Pediatric Optic Neuritis

Children differ from typical adult MS-associated ON.

Features include:

• Bilateral involvement more common
• Optic disc edema more common
• Severe initial visual loss
• Often excellent acuity recovery

MOG-IgG-associated disease is particularly important in pediatric ON.

Children with ON require assessment for:

• MOGAD
• MS
• AQP4-NMOSD
• Postinfectious inflammation

depending on phenotype.

⸻

Diagnosis

Typical optic neuritis remains primarily a:

Clinical diagnosis supported by MRI

However, modern evaluation increasingly aims to identify the underlying disease category.

⸻

MRI

The preferred imaging study is:

MRI brain and orbits with and without contrast

using dedicated orbital sequences including:

• Fat-suppressed T1 post-gadolinium
• T2/STIR
• Thin orbital sections

⸻

Orbital MRI Findings

Acute ON typically produces:

• Optic nerve enlargement
• T2 hyperintensity
• Gadolinium enhancement

MRI may also define:

• Anterior vs posterior involvement
• Length of involved nerve
• Chiasmal involvement
• Perineural enhancement

⸻

MRI and Multiple Sclerosis

Brain MRI should assess for characteristic demyelinating lesions involving:

• Periventricular regions
• Juxtacortical/cortical regions
• Infratentorial structures
• Corpus callosum

MRI findings contribute to assessment under modern:

McDonald criteria for multiple sclerosis

⸻

Spinal MRI

Spinal MRI is not required in every typical isolated case.

It becomes more useful when there are:

• Myelopathic symptoms
• Suspicion for NMOSD
• Suspicion for MOGAD
• Diagnostic uncertainty regarding MS

⸻

OCT

OCT is useful for measuring:

• Peripapillary RNFL
• Macular ganglion cell–inner plexiform layer

After ON, OCT may demonstrate:

• RNFL thinning
• Ganglion cell loss

⸻

Important OCT Timing Issue

During acute papillitis, RNFL may appear artificially thick because of edema.

The ganglion cell layer may therefore provide a more useful marker of early permanent neuronal injury.

Later, RNFL thinning becomes apparent.

⸻

Visual Evoked Potentials

VEP may show:

Prolonged P100 latency

reflecting slowed conduction from demyelination.

VEP can support evidence of:

• Prior optic nerve demyelination
• Subclinical optic neuropathy

but is not required in every typical case.

⸻

Laboratory Testing

Routine broad laboratory screening has low yield in a classic typical case.

Testing should be targeted toward:

• Atypical features
• Recurrent ON
• Bilateral disease
• Severe loss
• Poor recovery
• Systemic symptoms

⸻

AQP4-IgG Testing

Serum AQP4-IgG, preferably using a cell-based assay, should be considered particularly in:

• Severe optic neuritis
• Bilateral disease
• Chiasmal involvement
• Recurrent disease
• Poor recovery
• Associated myelitis

⸻

MOG-IgG Testing

Serum MOG-IgG, using a cell-based assay, should be considered in:

• Bilateral ON
• Recurrent ON
• Children
• Marked disc swelling
• Long-segment anterior optic nerve enhancement
• Steroid-responsive or steroid-dependent disease

Testing should be interpreted in the correct clinical context because low-positive results may be nonspecific.

⸻

Infectious Testing

Depending on phenotype and risk factors, consider:

• Syphilis serology
• TB testing
• Lyme serology where epidemiologically appropriate
• Bartonella testing
• Other infection-specific studies

⸻

Autoimmune Testing

Targeted testing may include:

• ACE / sarcoidosis evaluation
• ANA
• ANCA
• Sjögren antibodies

only when suggested by clinical findings.

⸻

Lumbar Puncture

Lumbar puncture is not routinely required in a classic adult case with supportive MRI.

It may be useful when:

• MRI is equivocal
• MS diagnosis remains uncertain
• CNS infection is considered
• Inflammatory or infiltrative disease is suspected

CSF studies may include:

• Oligoclonal bands
• IgG index
• Cell count
• Protein
• Infectious testing

⸻

Differential Diagnosis

Important mimics include:

• NAION
• Arteritic anterior ischemic optic neuropathy
• Compressive optic neuropathy
• Leber hereditary optic neuropathy
• Dominant optic atrophy
• Toxic/nutritional optic neuropathy
• Sarcoid optic neuropathy
• Syphilis
• Tuberculosis
• Neuroretinitis
• Optic perineuritis
• Retinal disease
• Functional visual disorder

⸻

Optic Neuritis vs NAION

Typical Optic Neuritis

• Younger patient
• Pain with eye movement
• Central visual dysfunction
• Dyschromatopsia prominent
• Disc often normal
• Recovery usually good

NAION

• Usually older patient
• Painless
• Disc edema always present acutely
• Altitudinal defect common
• “Disc at risk”
• Recovery more limited

⸻

Neuroretinitis

Neuroretinitis is characterized by:

• Optic disc edema
• Macular star

and is commonly associated with:

Bartonella henselae

A macular star is atypical for ordinary MS-associated ON.

⸻

Compressive Optic Neuropathy

Consider compression when there is:

• Slowly progressive visual loss
• Little or no pain
• Proptosis
• Optic pallor
• Poor spontaneous recovery
• Atypical MRI findings

⸻

Treatment Principles

Treatment depends on whether the patient has:

• Typical MS-associated optic neuritis
• MOGAD
• AQP4-NMOSD
• Another inflammatory/infectious optic neuropathy

⸻

Typical Demyelinating Optic Neuritis

Most typical cases recover substantially even without treatment.

High-dose corticosteroids:

Accelerate visual recovery but do not materially improve long-term final visual acuity in typical MS-associated ON.

⸻

High-Dose Corticosteroids

A traditional regimen is:

IV methylprednisolone 1 g/day for 3 days

Often used for:

• Significant visual impairment
• Bilateral disease
• Occupational or functional need for faster recovery
• Severe inflammation

Some clinicians use 3–5 days depending on disease context.

⸻

High-Dose Oral Corticosteroids

Modern evidence indicates that bioequivalent high-dose oral corticosteroids can provide similar efficacy to high-dose IV therapy in selected typical ON patients.

Therefore, the important distinction is:

High-dose therapy vs inadequate low-dose oral prednisone, rather than IV route alone.

⸻

Low-Dose Oral Prednisone

The older ONTT showed that:

Oral prednisone approximately 1 mg/kg/day alone should not be used for typical optic neuritis

because it was associated with an increased risk of recurrent ON.

This warning does not apply to appropriately dosed high-dose oral regimens.

⸻

Oral Taper

A taper is generally:

• Not required after a short course for typical MS-associated ON

However, tapering may be important in:

• MOGAD
• Optic perineuritis
• Steroid-dependent inflammatory disease

⸻

AQP4-NMOSD Treatment

AQP4-associated ON should be treated more aggressively because recovery may be poor.

Acute therapy generally includes:

• High-dose IV corticosteroids

If response is inadequate:

Early plasma exchange (PLEX)

should be considered.

Delay in escalation may reduce visual recovery.

⸻

MOGAD Treatment

Acute MOG optic neuritis usually responds well to:

• High-dose corticosteroids

However:

• Relapse may occur during rapid steroid taper
• Longer tapering courses are sometimes used in selected patients

Recurrent disease may require long-term immunotherapy.

⸻

Plasma Exchange

PLEX is particularly important for:

• Severe AQP4-NMOSD ON
• Severe steroid-refractory optic neuritis
• Selected MOGAD attacks with poor steroid response

It is not routinely required for uncomplicated typical MS-associated ON.

⸻

Long-Term MS Therapy

A patient with optic neuritis and evidence suggesting MS should be evaluated by neurology for:

Disease-modifying therapy (DMT)

Modern MS treatment includes many options beyond older interferon and glatiramer therapies.

Selection depends on:

• MRI burden
• Relapse risk
• Diagnostic criteria
• Comorbidities
• Pregnancy plans
• Patient preference

⸻

Clinically Isolated Syndrome

Patients with ON who do not yet fulfill MS criteria but have high-risk MRI findings may still be candidates for early neurologic treatment.

Neurology consultation is appropriate.

⸻

Pregnancy

Management is individualized.

Important considerations include:

• MRI without gadolinium can generally be performed when necessary
• Gadolinium is usually avoided unless essential
• High-dose corticosteroids may be used for significant attacks when benefits outweigh risks

Neurology, ophthalmology, and obstetric teams should coordinate management.

⸻

Follow-Up

Patients should be reassessed to ensure that the clinical course remains typical.

Monitor:

• Visual acuity
• Color vision
• RAPD
• Visual fields
• Optic nerve appearance
• OCT
• Neurologic symptoms

⸻

Expected Course

In typical MS-associated ON:

• Vision worsens over days
• Nadir generally occurs within 1–2 weeks
• Recovery begins within approximately 2–3 weeks
• Improvement continues for months

Failure to improve should prompt reconsideration of the diagnosis.

⸻

When to Re-Evaluate the Diagnosis

Urgently reconsider typical ON when:

• Vision continues worsening beyond 2 weeks
• No recovery begins within several weeks
• Repeated steroid dependence occurs
• Severe bilateral disease develops
• MRI pattern is atypical

Consider:

• AQP4-NMOSD
• MOGAD
• Compression
• Sarcoidosis
• Infection
• Ischemic optic neuropathy

⸻

Prognosis

Typical demyelinating ON generally has an excellent visual acuity prognosis.

Most patients recover to:

20/40 or better

and many recover to:

20/20

However, even when acuity returns to normal, patients may have persistent deficits in:

• Color vision
• Contrast sensitivity
• Motion perception
• Low-contrast acuity

⸻

Prognostic Factors

Poorer visual outcome is associated with:

• Profound initial visual loss
• AQP4-NMOSD
• Recurrent attacks
• Significant axonal loss
• Delayed treatment of severe atypical disease

⸻

Recurrence

Recurrent optic neuritis may occur with:

• MS
• MOGAD
• AQP4-NMOSD
• Chronic relapsing inflammatory optic neuropathy

Repeated attacks increase the risk of:

• Optic atrophy
• Permanent RNFL loss
• Persistent visual disability

⸻

Complications

Possible complications include:

• Optic atrophy
• RNFL thinning
• Ganglion cell loss
• Persistent dyschromatopsia
• Reduced contrast sensitivity
• Persistent visual field defect
• Recurrent optic neuritis
• Permanent visual loss

⸻

Ophthalmology Pearls

• Typical optic neuritis = painful, subacute monocular visual loss in a young adult, usually with dyschromatopsia and RAPD.
• Pain with eye movement is highly characteristic but not mandatory.
• The optic disc is often normal initially because many cases are retrobulbar.
• Color vision and contrast sensitivity may be disproportionately impaired compared with Snellen acuity.
• Visual deterioration usually reaches its nadir within 1–2 weeks, followed by spontaneous improvement within several weeks.
• MRI of the brain and orbits with dedicated fat-suppressed sequences is the key imaging study.
• Baseline brain MRI is the most important predictor of future MS risk after typical ON.
• MOGAD should be considered with bilateral disease, marked disc edema, recurrent attacks, or anterior long-segment enhancement.
• AQP4-NMOSD should be considered with severe visual loss, poor recovery, chiasmal/posterior involvement, bilateral disease, or associated myelitis.
• Serum AQP4-IgG and MOG-IgG cell-based assays are central tests in atypical optic neuritis.
• High-dose corticosteroids speed recovery in typical ON but do not substantially improve long-term final visual acuity.
• Avoid low-dose oral prednisone alone (~1 mg/kg/day) for typical ON because of increased recurrence risk; bioequivalent high-dose oral therapy is a different regimen and may be effective.
• Severe steroid-refractory or AQP4-associated ON may require early plasma exchange.
• A normal-looking optic nerve does not exclude optic neuritis.
• Lack of recovery, profound bilateral loss, marked disc hemorrhage, macular star, or prolonged progression should prompt reconsideration of the diagnosis.

Ophthalmology – Optic Nerve Hypoplasia

Basics

Description

Optic nerve hypoplasia (ONH) is a congenital, nonprogressive developmental anomaly in which the optic nerve contains fewer retinal ganglion cell axons than normal.

Typical features include:

• Abnormally small optic disc
• Pale or gray disc appearance
• Double-ring sign
• Reduced retinal nerve fiber layer
• Variable visual impairment

ONH may be:

• Unilateral
• Bilateral
• Symmetric
• Asymmetric

Bilateral disease is more common.

Visual acuity may range from:

20/20 to no light perception

and cannot be predicted reliably from disc appearance alone.

Epidemiology

ONH is one of the most common congenital optic nerve abnormalities encountered in pediatric ophthalmology.

Reported incidence and prevalence vary considerably between populations.

Recognition has increased because of:

• Better pediatric eye screening
• Improved neuroimaging
• Greater awareness of endocrine and neurologic associations

Risk Factors

Most cases occur without a clearly identifiable cause.

Reported prenatal associations include:

• Maternal diabetes
• Young maternal age
• Primiparity
• Prematurity
• Low birth weight
• Poor maternal weight gain
• Gestational bleeding
• Prenatal alcohol exposure
• Certain teratogenic drug exposures

Older reports described associations with agents such as:

• Phenytoin
• Quinine
• PCP
• LSD

but many of these associations are based on limited observational evidence.

Superior Segmental Optic Nerve Hypoplasia

A specific subtype is:

Superior segmental optic nerve hypoplasia

also called:

Topless disc syndrome

It is strongly associated with:

Maternal diabetes

Typical findings include:

• Superior optic disc pallor
• Superior RNFL thinning
• Abnormal superior vessel entry
• Corresponding inferior visual field defect

Genetics

Most ONH is sporadic.

Rare cases are associated with developmental genes including:

• HESX1
• SOX2
• OTX2
• PAX6
• Other genes involved in forebrain and pituitary development

HESX1 variants have been associated with:

• Septo-optic dysplasia
• Pituitary abnormalities
• Optic nerve hypoplasia

Familial recurrence is uncommon unless a defined genetic syndrome is present.

Pathophysiology

ONH results from:

Reduced development or survival of retinal ganglion cell axons

Possible mechanisms include:

• Abnormal axonal guidance
• Excessive developmental apoptosis
• Abnormal forebrain development
• Prenatal injury to developing visual pathways

The underlying structural deficit is permanent.

Pathology

Histologically there is:

• Reduced retinal ganglion cell population
• Reduced RNFL
• Fewer optic nerve axons
• Small optic nerve caliber

Associated Conditions

ONH may occur with abnormalities involving:

• Pituitary gland
• Hypothalamus
• Corpus callosum
• Septum pellucidum
• Cerebral cortex
• White matter

Septo-Optic Dysplasia

The classic concept of septo-optic dysplasia (SOD) includes combinations of:

• Optic nerve hypoplasia
• Midline brain abnormality
• Pituitary hormone deficiency

Traditionally, absence of the septum pellucidum was emphasized.

However:

The absence of the septum pellucidum is neither necessary nor sufficient for endocrine disease.

A child may have major pituitary dysfunction even with relatively normal brain imaging.

Endocrine Dysfunction

Endocrine abnormalities are among the most important associations.

Potential deficiencies include:

• Growth hormone
• ACTH/cortisol
• TSH
• Gonadotropins
• Antidiuretic hormone

Clinical consequences may include:

• Growth failure
• Hypoglycemia
• Central hypothyroidism
• Adrenal insufficiency
• Diabetes insipidus
• Precocious or delayed puberty

Important Endocrine Principle

A normal endocrine evaluation in infancy does not guarantee normal pituitary function later.

Some deficiencies emerge during childhood.

Therefore:

Long-term endocrine surveillance is important.

Neonatal Warning Signs

Possible early clues to pituitary dysfunction include:

• Prolonged neonatal jaundice
• Hypoglycemia
• Seizures
• Poor feeding
• Failure to thrive
• Micropenis
• Cryptorchidism
• Abnormal temperature regulation

CNS Abnormalities

Associated cerebral abnormalities may include:

• Corpus callosum hypoplasia
• Agenesis of corpus callosum
• Schizencephaly
• Cortical heterotopia
• Periventricular leukomalacia
• Encephalomalacia

Developmental Delay

Developmental delay is more common in:

• Bilateral ONH
• Severe visual impairment
• Corpus callosum abnormalities
• Hypothyroidism
• Other cerebral malformations

Potential problems include:

• Motor delay
• Language delay
• Cognitive impairment
• Behavioral difficulties

Diagnosis

Diagnosis is primarily clinical.

The main goals are to:

1. Confirm ONH.
2. Determine visual function.
3. Identify treatable amblyopia or refractive error.
4. Detect associated endocrine and neurologic disease.

History

Ask about:

• Poor visual behavior
• Nystagmus
• Strabismus
• Developmental delay
• Seizures
• Growth abnormalities
• Polyuria or polydipsia
• Neonatal jaundice
• Hypoglycemic episodes
• Maternal diabetes
• Prenatal exposures
• Family history of visual or developmental disorders

Presentation

Bilateral ONH

Often presents in infancy with:

• Poor fixation
• Reduced visual responsiveness
• Nystagmus

Nystagmus commonly appears during the first few months of life.

Unilateral ONH

May present later with:

• Strabismus
• Amblyopia
• Failed vision screening
• Incidental discovery

Visual Acuity

Vision can range from:

• Normal
• Mildly impaired
• Profoundly impaired
• NLP

Disc size alone does not reliably predict final acuity.

Pupillary Examination

A relative afferent pupillary defect may be present with:

• Unilateral ONH
• Markedly asymmetric bilateral ONH

Optic Disc Appearance

Typical findings include:

• Small optic disc
• Pale or gray disc
• Reduced neuroretinal tissue
• Double-ring sign
• Abnormal vessel pattern

Double-Ring Sign

The double-ring sign consists of:

• Small true optic nerve head
• Surrounding pale or pigmented ring corresponding to the larger scleral canal and surrounding tissue

It is a classic clue to ONH.

Disc–Macula Relationship

Because the optic disc is unusually small, the distance between:

• Optic disc center
• Fovea

appears disproportionately large relative to disc diameter.

A reduced:

disc diameter / disc–macula distance ratio

supports the diagnosis.

A value around ≤0.35 is often considered suggestive, though measurements vary.

Retinal Vessels

Retinal vessels may appear:

• Relatively large compared with the disc
• Tortuous
• Abnormally arranged

Visual Fields

When reliable testing becomes possible, defects may include:

• Generalized constriction
• Arcuate defect
• Central defect
• Altitudinal defect
• Sectoral field loss

Superior segmental ONH classically causes:

Inferior field loss

Optical Coherence Tomography

OCT can demonstrate:

• Reduced RNFL
• Reduced ganglion cell layer
• Small optic nerve head

It is useful for:

• Confirming structural hypoplasia
• Documenting asymmetry
• Distinguishing ONH from optic atrophy

Pediatric normative databases remain a limitation.

Fundus Photography

Useful for documenting:

• Disc morphology
• Disc size
• Double-ring sign
• Stability over time

ONH itself should remain structurally stable.

MRI

MRI of the brain and orbits is usually recommended in children with ONH to evaluate for:

• Pituitary abnormalities
• Hypothalamic abnormalities
• Corpus callosum abnormalities
• Midline brain defects
• Cortical malformations

MRI Pituitary Findings

Possible abnormalities include:

• Pituitary hypoplasia
• Abnormal pituitary stalk
• Ectopic posterior pituitary

An ectopic posterior pituitary is strongly associated with:

Anterior pituitary hormone deficiency

However:

Normal pituitary anatomy does not exclude endocrinopathy.

Endocrine Evaluation

Pediatric endocrine assessment should be strongly considered for children with ONH.

Initial testing may include:

• Morning cortisol
• Glucose
• TSH
• Free T4
• IGF-1
• IGFBP-3
• Electrolytes
• Prolactin

Additional testing depends on:

• Age
• Growth pattern
• Pubertal status
• Symptoms

Diabetes Insipidus Evaluation

If there is:

• Polyuria
• Polydipsia
• Hypernatremia

consider:

• Serum sodium
• Serum osmolality
• Urine osmolality

for possible central diabetes insipidus.

Pubertal Assessment

Monitor for:

• Precocious puberty
• Delayed puberty
• Abnormal growth velocity

Endocrinology may assess:

• LH
• FSH
• Testosterone or estradiol

when appropriate.

Neurologic Evaluation

Consider pediatric neurology referral for:

• Seizures
• Developmental delay
• Abnormal tone
• Major MRI abnormalities
• Suspected cortical visual impairment

Differential Diagnosis

Important differentials include:

• Optic atrophy
• Optic disc coloboma
• Morning glory disc anomaly
• Ocular albinism
• Small physiologic optic disc

ONH vs Optic Atrophy

Optic Nerve Hypoplasia

• Congenitally small disc
• Double-ring sign
• Reduced axon number from development
• Nonprogressive

Optic Atrophy

• Previously normal-sized nerve
• Acquired axonal loss
• Pallor predominates
• Often a history of prior neurologic or ocular injury

Ocular Albinism

May cause:

• Nystagmus
• Reduced visual acuity
• Foveal hypoplasia
• Iris transillumination
• Fundus hypopigmentation

but the optic nerve is not necessarily small.

Optic Disc Coloboma

Typically shows:

• Inferior bowl-shaped excavation
• White glistening base
• Embryonic fissure distribution

rather than uniform disc hypoplasia.

Treatment

There is no treatment capable of regenerating the hypoplastic optic nerve.

Management focuses on:

• Maximizing existing vision
• Treating amblyopia
• Correcting refractive error
• Managing strabismus
• Treating endocrine disease
• Providing developmental and low-vision support

Refractive Correction

Perform cycloplegic refraction and correct:

• Hyperopia
• Myopia
• Astigmatism
• Anisometropia

Amblyopia

Amblyopia may coexist with structural visual impairment.

Treat when appropriate with:

• Optical correction
• Patching
• Atropine penalization

Treatment should be individualized according to residual visual potential.

Strabismus

Management may include:

• Refractive correction
• Amblyopia treatment
• Strabismus surgery

Surgery may be performed for:

• Alignment
• Cosmetic benefit
• Binocular function when possible

Nystagmus

Nystagmus generally reflects impaired early visual input.

Surgery may be considered only in selected cases with:

• Significant abnormal head posture
• Null point
• Associated strabismus

Protective Eyewear

When one eye has much better vision than the other, recommend:

Impact-resistant protective spectacles

to protect the better-seeing eye.

Low-Vision Services

Children with significant bilateral impairment should be referred early for:

• Low-vision rehabilitation
• Educational accommodations
• Early intervention services
• Orientation and mobility training
• Adaptive technology

Endocrine Treatment

Identified deficiencies require prompt treatment.

Examples include:

• Hydrocortisone for adrenal insufficiency
• Levothyroxine for central hypothyroidism
• Growth hormone when appropriate
• Desmopressin for central diabetes insipidus

Critical Safety Issue – ACTH Deficiency

Unrecognized cortisol deficiency can become life-threatening during:

• Infection
• Surgery
• Trauma
• Fasting

Therefore endocrine assessment in ONH is important even when the child appears otherwise well.

Stem Cell Therapy

Stem cell treatments marketed for ONH have not been proven to regenerate the optic nerve or improve visual function.

They are not established therapy.

Follow-Up

Ophthalmic follow-up should monitor:

• Visual acuity
• Refraction
• Amblyopia
• Strabismus
• Nystagmus
• Functional vision

Children may require:

• More frequent review during visual development and amblyopia treatment
• Annual review once stable

Long-Term Endocrine Monitoring

Monitor:

• Height
• Weight
• Growth velocity
• Pubertal development
• Symptoms of adrenal or thyroid dysfunction
• Polyuria/polydipsia

Repeated endocrine assessment may be needed even after an initially normal evaluation.

Prognosis

ONH itself is generally:

Stable and nonprogressive

Visual acuity may appear to improve with age because of:

• Visual maturation
• Better attention
• Improved testing cooperation
• Amblyopia therapy

This does not represent regrowth of the optic nerve.

Prognostic Factors

Visual outcome depends on:

• Severity of axonal hypoplasia
• Unilateral vs bilateral disease
• Amblyopia
• Refractive error
• Associated cerebral visual impairment
• Neurologic abnormalities

Complications

Major complications and associated conditions include:

• Amblyopia
• Strabismus
• Nystagmus
• Severe visual impairment
• Developmental delay
• Growth hormone deficiency
• Central hypothyroidism
• ACTH deficiency
• Diabetes insipidus
• Pubertal abnormalities
• Seizures
• Other CNS malformations

Ophthalmology Pearls

• Optic nerve hypoplasia is a congenital, nonprogressive small optic nerve caused by reduced retinal ganglion cell axons.
• The classic fundus sign is a small pale optic disc with a double-ring sign.
• Bilateral ONH often presents with poor visual behavior and infantile nystagmus; unilateral disease often presents with strabismus.
• Visual acuity ranges from normal to NLP and cannot be accurately predicted from disc appearance.
• Superior segmental ONH (“topless disc”) is classically associated with maternal diabetes and produces an inferior visual field defect.
• The most clinically important systemic association is hypothalamic-pituitary dysfunction.
• Growth hormone deficiency is common, but ACTH/cortisol deficiency is potentially life-threatening and must not be missed.
• Normal MRI does not exclude endocrine dysfunction.
• Endocrine abnormalities can develop later, so longitudinal growth and endocrine surveillance is essential.
• MRI should assess the pituitary, hypothalamus, corpus callosum, and cerebral development.
• ONH must be distinguished from optic atrophy, in which the nerve was previously normal and subsequently lost axons.
• There is no therapy that regenerates the hypoplastic nerve; treatment focuses on refractive correction, amblyopia therapy, strabismus care, endocrine management, and low-vision support.

Medicine – Symptoms and Signs of Uraemia

Uraemia is the clinical syndrome that develops when advanced kidney failure leads to retention of uraemic toxins, together with disturbances in fluid balance, electrolytes, acid–base status, endocrine function and haemostasis.

It is important to distinguish uraemia from simply having a high blood urea concentration. A patient is uraemic when they develop clinical manifestations of severe kidney dysfunction, not merely because the laboratory urea level is elevated.

1. Neurological Features

Neurological symptoms are common in advanced uraemia and can range from mild cognitive changes to severe encephalopathy.

Early features may include:

Malaise.

Fatigue.

Poor concentration.

Sleep disturbance.

Irritability or reduced mental alertness.

Malaise

Malaise is common and reflects the combined effects of:

Toxin accumulation.

Anaemia of CKD.

Metabolic abnormalities.

Poor nutrition.

Patients often describe generalized weakness and reduced exercise tolerance.

Depression and Cognitive Change

Patients with advanced kidney disease may experience:

Low mood.

Depressive symptoms.

Poor concentration.

Slowed thinking.

However, depression is not specific for uraemia and may also result from the psychological burden of chronic disease.

As uraemia becomes more severe, neurological dysfunction may progress to:

Confusion and encephalopathy.

Uraemic Encephalopathy

Uraemic encephalopathy indicates severe renal dysfunction.

Possible manifestations include:

Confusion.

Drowsiness.

Disorientation.

Asterixis.

Myoclonus.

Seizures.

Coma.

Its presence is an important indication for:

Urgent kidney replacement therapy/dialysis.

Fits

The older term:

Fits

is better written as:

Seizures.

Seizures can occur in severe uraemia, but other causes should also be considered, including:

Severe hypertension.

Electrolyte abnormalities.

Hypoglycaemia.

Drug toxicity.

CNS disease.

Coma

Very severe uraemic encephalopathy may eventually lead to:

Coma.

This represents advanced disease and requires urgent assessment and treatment.

2. Peripheral Neurological Manifestations

Chronic uraemia may also affect peripheral nerves.

Patients can develop:

Distal symmetrical peripheral neuropathy.

Typical symptoms include:

Numbness.

Tingling.

Burning sensations.

Restless legs.

Reduced reflexes in advanced cases.

This is usually seen in prolonged, advanced kidney disease.

3. Cardiorespiratory Features

Severe uraemia can affect the:

Pericardium.

Pleura.

Lungs.

Respiratory pattern.

Some manifestations arise directly from uraemia, whereas others result from fluid overload or metabolic acidosis.

4. Uraemic Pericarditis

Pericarditis is an important and potentially serious manifestation of uraemia.

Patients may develop:

Chest pain.

Pericardial friction rub.

Pericardial effusion.

In severe cases, the effusion may progress to:

Cardiac tamponade.

Clinical Importance of Uraemic Pericarditis

Uraemic pericarditis is a classic indication for:

Urgent dialysis.

The pericardial inflammation reflects advanced uraemic toxicity rather than simply elevated urea itself.

5. Pleurisy and Pleural Disease

The original notes include:

Pleurisy.

Uraemic inflammation can occasionally affect the pleura and cause:

Pleuritic chest pain.

Pleural effusion.

However, in advanced kidney failure, pleural effusions are often more commonly related to:

Fluid overload or heart failure.

6. Pulmonary Oedema

An important cardiorespiratory complication not listed in the original notes is:

Pulmonary oedema.

Impaired sodium and water excretion can cause:

Fluid overload.

This may produce:

Dyspnoea.

Orthopnoea.

Basal crackles.

Hypoxaemia.

Severe refractory pulmonary oedema may require:

Urgent dialysis.

7. Kussmaul Breathing

The original notes correctly associate:

Kussmaul breathing

with:

Metabolic acidosis.

Advanced kidney failure impairs the ability to excrete:

Hydrogen ions

and regenerate:

Bicarbonate.

This may cause significant metabolic acidosis.

Kussmaul Respirations

Kussmaul breathing consists of:

Deep, rapid, laboured respirations.

It represents respiratory compensation for:

Severe metabolic acidosis.

The patient increases ventilation to reduce:

Carbon dioxide.

Therefore:

ADVANCED RENAL FAILURE + DEEP RAPID BREATHING → THINK METABOLIC ACIDOSIS.

8. Dermatological Features

The skin may show several manifestations in advanced kidney disease.

These include:

Pruritus.

Easy bruising or purpura.

Altered skin pigmentation.

Dry skin.

9. Uraemic Pruritus

Pruritus is common in advanced CKD, particularly in patients receiving dialysis.

The mechanism is complex and may involve:

Uraemic toxins.

Inflammation.

Abnormal mineral metabolism.

Peripheral nerve dysfunction.

Dry skin.

The itching can be severe and significantly impair sleep and quality of life.

10. Purpura and Easy Bruising

The original notes correctly associate:

Purpura

with abnormal platelet function.

Uraemia causes primarily a:

Qualitative platelet dysfunction.

Platelet number may be normal, but platelet:

Adhesion and aggregation

are impaired.

Uraemic Bleeding Tendency

Patients may develop:

Easy bruising.

Purpura.

Epistaxis.

Gingival bleeding.

Bleeding from venepuncture sites.

GI bleeding.

Therefore:

URAEMIA → PLATELET DYSFUNCTION → BLEEDING TENDENCY.

11. Skin Pigmentation

Patients with advanced chronic kidney disease may develop:

Pale, yellow-brown or sallow skin pigmentation.

This reflects several factors, including:

Anaemia.

Retention of pigmented metabolites.

The traditional description of increased pigmentation is therefore valid, although it is not specific to uraemia.

12. Uraemic Frost

A rare historical manifestation of extremely severe uraemia is:

Uraemic frost.

This occurs when very high concentrations of urea are excreted in sweat and crystallise on the skin as a:

White powdery deposit.

It is now uncommon because severe kidney failure is generally treated earlier.

13. Gastrointestinal Features

Gastrointestinal symptoms are common in uraemia and often contribute to:

Poor oral intake.

Weight loss.

Malnutrition.

Important symptoms include:

Anorexia.

Nausea.

Vomiting.

Altered bowel habits.

GI bleeding.

14. Anorexia

Loss of appetite is a common feature of advanced uraemia.

Patients may also complain of:

Early satiety.

Food aversion.

Unpleasant or metallic taste.

This can lead to reduced nutritional intake.

15. Nausea and Vomiting

As uraemic toxin levels rise, patients commonly develop:

Nausea and vomiting.

Persistent vomiting can further worsen:

Volume depletion.

Electrolyte abnormalities.

Malnutrition.

Severe persistent uraemic gastrointestinal symptoms can support the need for dialysis.

16. Uraemic Taste and Breath

Some patients with severe uraemia develop:

Metallic taste

or unpleasant breath sometimes described as:

Uraemic fetor.

This is caused partly by breakdown of urea in saliva to ammonia-containing compounds.

17. Gastrointestinal Bleeding

The original notes correctly include:

GI bleeding.

This may occur because uraemia causes:

Platelet dysfunction.

Therefore bleeding may arise from mucosal lesions that would otherwise produce less severe bleeding.

18. Diarrhoea

Diarrhoea may occur in uraemic patients, although it is relatively nonspecific.

Possible contributors include:

Uraemic gastrointestinal irritation.

Medication effects.

Infection.

Altered gut function.

Therefore diarrhoea should not automatically be attributed to uraemia without considering other causes.

19. Constipation

Constipation may also occur in advanced CKD.

Possible contributors include:

Reduced mobility.

Low fluid intake.

Dietary restrictions.

Medications.

Phosphate binders or iron therapy.

Therefore constipation is common in kidney patients but is not a highly specific manifestation of uraemic toxin accumulation.

20. Haematological Features

An important manifestation of advanced CKD is:

Anaemia.

The major mechanism is:

Relative erythropoietin deficiency.

This produces a predominantly:

Normocytic, normochromic anaemia.

Symptoms of Anaemia

Anaemia can contribute to:

Fatigue.

Weakness.

Dyspnoea on exertion.

Palpitations.

Poor concentration.

Thus some symptoms attributed to uraemia may actually be partly caused by:

CKD-associated anaemia.

21. Platelet Dysfunction

Uraemia affects platelet function rather than usually causing severe thrombocytopenia.

The major abnormality is:

Impaired platelet adhesion and aggregation.

Therefore a patient can bleed despite having:

A relatively normal platelet count.

22. Fluid and Electrolyte Manifestations

Advanced renal failure may produce:

Fluid overload.

Hyperkalaemia.

Metabolic acidosis.

These are not simply symptoms of uraemia but are major consequences of severe renal dysfunction.

23. Hyperkalaemia

Hyperkalaemia may be clinically silent or may cause:

Muscle weakness.

Palpitations.

Cardiac arrhythmias.

Severe hyperkalaemia may result in:

Cardiac arrest.

This is one of the most dangerous complications of advanced kidney failure.

24. Fluid Overload

Salt and water retention may produce:

Peripheral oedema.

Raised JVP.

Hypertension.

Pulmonary oedema.

Breathlessness.

Therefore the cardiorespiratory assessment is crucial in patients with advanced renal dysfunction.

25. Endocrine and Reproductive Features

Advanced CKD may disrupt endocrine and reproductive function.

Possible features include:

Reduced libido.

Erectile dysfunction.

Menstrual disturbance.

Reduced fertility.

These are more typical of prolonged advanced kidney disease rather than acute uraemia.

26. Musculoskeletal Features

Patients with advanced CKD may also experience:

Muscle weakness.

Muscle cramps.

Bone pain.

Bone symptoms are usually related more specifically to:

CKD-mineral and bone disorder / renal osteodystrophy

than to uraemia itself.

27. Neurological Features – Note Form

Malaise/fatigue:

Common early symptoms.

Cognitive change:

Poor concentration, confusion and drowsiness.

Depressive symptoms:

May occur but are not specific.

Asterixis/myoclonus:

May occur in uraemic encephalopathy.

Seizures:

Severe uraemic encephalopathy.

Coma:

Very advanced neurological dysfunction.

Peripheral neuropathy/restless legs:

May occur in chronic advanced uraemia.

28. Cardiorespiratory Features – Note Form

Pericarditis:

Chest pain + pericardial rub ± effusion.

Important dialysis indication.

Pleuritic disease:

Pleuritic pain/effusion may occur.

Pulmonary oedema:

Fluid overload → dyspnoea, orthopnoea and crackles.

Kussmaul breathing:

Deep rapid respiration due to severe metabolic acidosis.

29. Dermatological Features – Note Form

Pruritus:

Common in advanced CKD.

Purpura/easy bruising:

Uraemic platelet dysfunction.

Pigmentation:

Sallow/yellow-brown skin may occur.

Uraemic frost:

Rare, severe untreated uraemia.

30. Gastrointestinal Features – Note Form

Anorexia:

Loss of appetite.

Nausea and vomiting:

Common in severe uraemia.

Metallic taste/uraemic fetor:

May occur.

GI bleeding:

Related partly to platelet dysfunction.

Diarrhoea or constipation:

Can occur but are relatively nonspecific and may have additional causes.

31. Important Corrections to the Original Notes

The term:

“Fits”

is better replaced with:

SEIZURES.

Depression may occur in advanced kidney disease, but it is not specific for uraemic encephalopathy. More characteristic severe neurological findings include:

CONFUSION + DROWSINESS + ASTERIXIS + SEIZURES + COMA.

Pleurisy can occur in uraemia, but in advanced kidney disease respiratory symptoms are also commonly caused by:

FLUID OVERLOAD AND PULMONARY OEDEMA.

Purpura occurs because uraemia produces:

QUALITATIVE PLATELET DYSFUNCTION, especially impaired adhesion and aggregation, rather than simply a low platelet count.

Diarrhoea and constipation can occur but are relatively nonspecific. The more characteristic GI features are:

ANOREXIA + NAUSEA + VOMITING + METALLIC TASTE ± GI BLEEDING.

Key Clinical Pattern

Think of uraemia when advanced kidney dysfunction is accompanied by:

NEUROLOGICAL → CONFUSION, ASTERIXIS, SEIZURES, COMA.

CARDIAC → URAEMIC PERICARDITIS.

RESPIRATORY → KUSSMAUL BREATHING FROM ACIDOSIS ± PULMONARY OEDEMA.

SKIN → PRURITUS + EASY BRUISING/PURPURA.

GI → ANOREXIA + NAUSEA + VOMITING + METALLIC TASTE.

HAEMATOLOGICAL → PLATELET DYSFUNCTION + ANAEMIA OF CKD.

The most important clinical point is:

URAEMIA IS A CLINICAL SYNDROME, NOT SIMPLY A HIGH BLOOD UREA LEVEL.

And severe manifestations such as:

URAEMIC ENCEPHALOPATHY, PERICARDITIS OR SIGNIFICANT URAEMIC BLEEDING

are important indications for:

URGENT DIALYSIS / KIDNEY REPLACEMENT THERAPY.

Medicine – Symptoms and Signs of Uraemia

Uraemia is the clinical syndrome that develops when advanced kidney failure leads to retention of uraemic toxins, together with disturbances in fluid balance, electrolytes, acid–base status, endocrine function and haemostasis.

It is important to distinguish uraemia from simply having a high blood urea concentration. A patient is uraemic when they develop clinical manifestations of severe kidney dysfunction, not merely because the laboratory urea level is elevated.

1. Neurological Features

Neurological symptoms are common in advanced uraemia and can range from mild cognitive changes to severe encephalopathy.

Early features may include:

Malaise.

Fatigue.

Poor concentration.

Sleep disturbance.

Irritability or reduced mental alertness.

Malaise

Malaise is common and reflects the combined effects of:

Toxin accumulation.

Anaemia of CKD.

Metabolic abnormalities.

Poor nutrition.

Patients often describe generalized weakness and reduced exercise tolerance.

Depression and Cognitive Change

Patients with advanced kidney disease may experience:

Low mood.

Depressive symptoms.

Poor concentration.

Slowed thinking.

However, depression is not specific for uraemia and may also result from the psychological burden of chronic disease.

As uraemia becomes more severe, neurological dysfunction may progress to:

Confusion and encephalopathy.

Uraemic Encephalopathy

Uraemic encephalopathy indicates severe renal dysfunction.

Possible manifestations include:

Confusion.

Drowsiness.

Disorientation.

Asterixis.

Myoclonus.

Seizures.

Coma.

Its presence is an important indication for:

Urgent kidney replacement therapy/dialysis.

Fits

The older term:

Fits

is better written as:

Seizures.

Seizures can occur in severe uraemia, but other causes should also be considered, including:

Severe hypertension.

Electrolyte abnormalities.

Hypoglycaemia.

Drug toxicity.

CNS disease.

Coma

Very severe uraemic encephalopathy may eventually lead to:

Coma.

This represents advanced disease and requires urgent assessment and treatment.

2. Peripheral Neurological Manifestations

Chronic uraemia may also affect peripheral nerves.

Patients can develop:

Distal symmetrical peripheral neuropathy.

Typical symptoms include:

Numbness.

Tingling.

Burning sensations.

Restless legs.

Reduced reflexes in advanced cases.

This is usually seen in prolonged, advanced kidney disease.

3. Cardiorespiratory Features

Severe uraemia can affect the:

Pericardium.

Pleura.

Lungs.

Respiratory pattern.

Some manifestations arise directly from uraemia, whereas others result from fluid overload or metabolic acidosis.

4. Uraemic Pericarditis

Pericarditis is an important and potentially serious manifestation of uraemia.

Patients may develop:

Chest pain.

Pericardial friction rub.

Pericardial effusion.

In severe cases, the effusion may progress to:

Cardiac tamponade.

Clinical Importance of Uraemic Pericarditis

Uraemic pericarditis is a classic indication for:

Urgent dialysis.

The pericardial inflammation reflects advanced uraemic toxicity rather than simply elevated urea itself.

5. Pleurisy and Pleural Disease

The original notes include:

Pleurisy.

Uraemic inflammation can occasionally affect the pleura and cause:

Pleuritic chest pain.

Pleural effusion.

However, in advanced kidney failure, pleural effusions are often more commonly related to:

Fluid overload or heart failure.

6. Pulmonary Oedema

An important cardiorespiratory complication not listed in the original notes is:

Pulmonary oedema.

Impaired sodium and water excretion can cause:

Fluid overload.

This may produce:

Dyspnoea.

Orthopnoea.

Basal crackles.

Hypoxaemia.

Severe refractory pulmonary oedema may require:

Urgent dialysis.

7. Kussmaul Breathing

The original notes correctly associate:

Kussmaul breathing

with:

Metabolic acidosis.

Advanced kidney failure impairs the ability to excrete:

Hydrogen ions

and regenerate:

Bicarbonate.

This may cause significant metabolic acidosis.

Kussmaul Respirations

Kussmaul breathing consists of:

Deep, rapid, laboured respirations.

It represents respiratory compensation for:

Severe metabolic acidosis.

The patient increases ventilation to reduce:

Carbon dioxide.

Therefore:

ADVANCED RENAL FAILURE + DEEP RAPID BREATHING → THINK METABOLIC ACIDOSIS.

8. Dermatological Features

The skin may show several manifestations in advanced kidney disease.

These include:

Pruritus.

Easy bruising or purpura.

Altered skin pigmentation.

Dry skin.

9. Uraemic Pruritus

Pruritus is common in advanced CKD, particularly in patients receiving dialysis.

The mechanism is complex and may involve:

Uraemic toxins.

Inflammation.

Abnormal mineral metabolism.

Peripheral nerve dysfunction.

Dry skin.

The itching can be severe and significantly impair sleep and quality of life.

10. Purpura and Easy Bruising

The original notes correctly associate:

Purpura

with abnormal platelet function.

Uraemia causes primarily a:

Qualitative platelet dysfunction.

Platelet number may be normal, but platelet:

Adhesion and aggregation

are impaired.

Uraemic Bleeding Tendency

Patients may develop:

Easy bruising.

Purpura.

Epistaxis.

Gingival bleeding.

Bleeding from venepuncture sites.

GI bleeding.

Therefore:

URAEMIA → PLATELET DYSFUNCTION → BLEEDING TENDENCY.

11. Skin Pigmentation

Patients with advanced chronic kidney disease may develop:

Pale, yellow-brown or sallow skin pigmentation.

This reflects several factors, including:

Anaemia.

Retention of pigmented metabolites.

The traditional description of increased pigmentation is therefore valid, although it is not specific to uraemia.

12. Uraemic Frost

A rare historical manifestation of extremely severe uraemia is:

Uraemic frost.

This occurs when very high concentrations of urea are excreted in sweat and crystallise on the skin as a:

White powdery deposit.

It is now uncommon because severe kidney failure is generally treated earlier.

13. Gastrointestinal Features

Gastrointestinal symptoms are common in uraemia and often contribute to:

Poor oral intake.

Weight loss.

Malnutrition.

Important symptoms include:

Anorexia.

Nausea.

Vomiting.

Altered bowel habits.

GI bleeding.

14. Anorexia

Loss of appetite is a common feature of advanced uraemia.

Patients may also complain of:

Early satiety.

Food aversion.

Unpleasant or metallic taste.

This can lead to reduced nutritional intake.

15. Nausea and Vomiting

As uraemic toxin levels rise, patients commonly develop:

Nausea and vomiting.

Persistent vomiting can further worsen:

Volume depletion.

Electrolyte abnormalities.

Malnutrition.

Severe persistent uraemic gastrointestinal symptoms can support the need for dialysis.

16. Uraemic Taste and Breath

Some patients with severe uraemia develop:

Metallic taste

or unpleasant breath sometimes described as:

Uraemic fetor.

This is caused partly by breakdown of urea in saliva to ammonia-containing compounds.

17. Gastrointestinal Bleeding

The original notes correctly include:

GI bleeding.

This may occur because uraemia causes:

Platelet dysfunction.

Therefore bleeding may arise from mucosal lesions that would otherwise produce less severe bleeding.

18. Diarrhoea

Diarrhoea may occur in uraemic patients, although it is relatively nonspecific.

Possible contributors include:

Uraemic gastrointestinal irritation.

Medication effects.

Infection.

Altered gut function.

Therefore diarrhoea should not automatically be attributed to uraemia without considering other causes.

19. Constipation

Constipation may also occur in advanced CKD.

Possible contributors include:

Reduced mobility.

Low fluid intake.

Dietary restrictions.

Medications.

Phosphate binders or iron therapy.

Therefore constipation is common in kidney patients but is not a highly specific manifestation of uraemic toxin accumulation.

20. Haematological Features

An important manifestation of advanced CKD is:

Anaemia.

The major mechanism is:

Relative erythropoietin deficiency.

This produces a predominantly:

Normocytic, normochromic anaemia.

Symptoms of Anaemia

Anaemia can contribute to:

Fatigue.

Weakness.

Dyspnoea on exertion.

Palpitations.

Poor concentration.

Thus some symptoms attributed to uraemia may actually be partly caused by:

CKD-associated anaemia.

21. Platelet Dysfunction

Uraemia affects platelet function rather than usually causing severe thrombocytopenia.

The major abnormality is:

Impaired platelet adhesion and aggregation.

Therefore a patient can bleed despite having:

A relatively normal platelet count.

22. Fluid and Electrolyte Manifestations

Advanced renal failure may produce:

Fluid overload.

Hyperkalaemia.

Metabolic acidosis.

These are not simply symptoms of uraemia but are major consequences of severe renal dysfunction.

23. Hyperkalaemia

Hyperkalaemia may be clinically silent or may cause:

Muscle weakness.

Palpitations.

Cardiac arrhythmias.

Severe hyperkalaemia may result in:

Cardiac arrest.

This is one of the most dangerous complications of advanced kidney failure.

24. Fluid Overload

Salt and water retention may produce:

Peripheral oedema.

Raised JVP.

Hypertension.

Pulmonary oedema.

Breathlessness.

Therefore the cardiorespiratory assessment is crucial in patients with advanced renal dysfunction.

25. Endocrine and Reproductive Features

Advanced CKD may disrupt endocrine and reproductive function.

Possible features include:

Reduced libido.

Erectile dysfunction.

Menstrual disturbance.

Reduced fertility.

These are more typical of prolonged advanced kidney disease rather than acute uraemia.

26. Musculoskeletal Features

Patients with advanced CKD may also experience:

Muscle weakness.

Muscle cramps.

Bone pain.

Bone symptoms are usually related more specifically to:

CKD-mineral and bone disorder / renal osteodystrophy

than to uraemia itself.

27. Neurological Features – Note Form

Malaise/fatigue:

Common early symptoms.

Cognitive change:

Poor concentration, confusion and drowsiness.

Depressive symptoms:

May occur but are not specific.

Asterixis/myoclonus:

May occur in uraemic encephalopathy.

Seizures:

Severe uraemic encephalopathy.

Coma:

Very advanced neurological dysfunction.

Peripheral neuropathy/restless legs:

May occur in chronic advanced uraemia.

28. Cardiorespiratory Features – Note Form

Pericarditis:

Chest pain + pericardial rub ± effusion.

Important dialysis indication.

Pleuritic disease:

Pleuritic pain/effusion may occur.

Pulmonary oedema:

Fluid overload → dyspnoea, orthopnoea and crackles.

Kussmaul breathing:

Deep rapid respiration due to severe metabolic acidosis.

29. Dermatological Features – Note Form

Pruritus:

Common in advanced CKD.

Purpura/easy bruising:

Uraemic platelet dysfunction.

Pigmentation:

Sallow/yellow-brown skin may occur.

Uraemic frost:

Rare, severe untreated uraemia.

30. Gastrointestinal Features – Note Form

Anorexia:

Loss of appetite.

Nausea and vomiting:

Common in severe uraemia.

Metallic taste/uraemic fetor:

May occur.

GI bleeding:

Related partly to platelet dysfunction.

Diarrhoea or constipation:

Can occur but are relatively nonspecific and may have additional causes.

31. Important Corrections to the Original Notes

The term:

“Fits”

is better replaced with:

SEIZURES.

Depression may occur in advanced kidney disease, but it is not specific for uraemic encephalopathy. More characteristic severe neurological findings include:

CONFUSION + DROWSINESS + ASTERIXIS + SEIZURES + COMA.

Pleurisy can occur in uraemia, but in advanced kidney disease respiratory symptoms are also commonly caused by:

FLUID OVERLOAD AND PULMONARY OEDEMA.

Purpura occurs because uraemia produces:

QUALITATIVE PLATELET DYSFUNCTION, especially impaired adhesion and aggregation, rather than simply a low platelet count.

Diarrhoea and constipation can occur but are relatively nonspecific. The more characteristic GI features are:

ANOREXIA + NAUSEA + VOMITING + METALLIC TASTE ± GI BLEEDING.

Key Clinical Pattern

Think of uraemia when advanced kidney dysfunction is accompanied by:

NEUROLOGICAL → CONFUSION, ASTERIXIS, SEIZURES, COMA.

CARDIAC → URAEMIC PERICARDITIS.

RESPIRATORY → KUSSMAUL BREATHING FROM ACIDOSIS ± PULMONARY OEDEMA.

SKIN → PRURITUS + EASY BRUISING/PURPURA.

GI → ANOREXIA + NAUSEA + VOMITING + METALLIC TASTE.

HAEMATOLOGICAL → PLATELET DYSFUNCTION + ANAEMIA OF CKD.

The most important clinical point is:

URAEMIA IS A CLINICAL SYNDROME, NOT SIMPLY A HIGH BLOOD UREA LEVEL.

And severe manifestations such as:

URAEMIC ENCEPHALOPATHY, PERICARDITIS OR SIGNIFICANT URAEMIC BLEEDING

are important indications for:

URGENT DIALYSIS / KIDNEY REPLACEMENT THERAPY.

Medicine – Causes of Urinary Frequency

Urinary frequency means passing urine more often than usual. It does not necessarily mean that the total urine volume is increased. A patient may void frequently because the bladder is irritated, its capacity is reduced, there is incomplete emptying, or bladder control is abnormal.

The first useful distinction is between frequency and polyuria. Frequency refers to repeated small voids, whereas polyuria means an abnormally large total urine volume.

1. Urinary Tract Infection

Infection is one of the most common causes of urinary frequency.

Inflammation of the urinary tract makes the bladder or urethra more sensitive, so even a small amount of urine can trigger the urge to void.

Cystitis

Cystitis is a lower urinary tract infection involving the bladder.

Typical symptoms include:

Urinary frequency.

Urgency.

Dysuria.

Suprapubic discomfort.

The urine may also show:

Pyuria.

Bacteriuria.

Microscopic haematuria.

Therefore:

FREQUENCY + DYSURIA + URGENCY → THINK CYSTITIS.

Urethritis

Urethritis is inflammation of the urethra and may also cause urinary frequency.

Other symptoms can include:

Dysuria.

Urethral discharge.

Urethral irritation.

Sexually transmitted infections such as:

Chlamydia

or

Gonorrhoea

may be responsible in appropriate patients.

Prostatitis

Inflammation or infection of the prostate can cause:

Frequency.

Urgency.

Dysuria.

Pelvic or perineal pain.

Acute bacterial prostatitis may also cause:

Fever and systemic illness.

2. Prostatic Enlargement

The original notes correctly include:

Prostatic hypertrophy.

The preferred modern term is usually:

Benign prostatic hyperplasia – BPH.

BPH can obstruct urinary flow and prevent complete emptying of the bladder.

Why BPH Causes Frequency

When the bladder does not empty completely, a:

Post-void residual volume

remains.

The bladder therefore reaches its functional capacity again more quickly.

This leads to:

Frequency.

Nocturia.

Urgency.

Other BPH Symptoms

BPH can also produce voiding symptoms such as:

Weak urinary stream.

Hesitancy.

Intermittency.

Straining.

Terminal dribbling.

Feeling of incomplete emptying.

Therefore:

OLDER MAN + FREQUENCY + WEAK STREAM + NOCTURIA → THINK BPH.

3. Bladder Tumour

A bladder tumour can cause urinary frequency by:

Irritating the bladder mucosa

or reducing effective bladder capacity.

Frequency may occur together with:

Urgency.

Dysuria.

However, the classic warning feature of bladder malignancy remains:

Painless visible haematuria.

Important Clinical Point

A patient with persistent irritative urinary symptoms, especially with:

Haematuria

or relevant risk factors such as smoking, should be evaluated for:

Bladder malignancy.

4. Urethral Stricture

A urethral stricture is narrowing of the urethral lumen.

It may result from:

Previous instrumentation.

Trauma.

Previous infection or urethritis.

Surgery.

The narrowing causes:

Bladder outlet obstruction.

Symptoms of Urethral Stricture

Symptoms may include:

Frequency.

Weak urinary stream.

Straining.

Incomplete emptying.

Post-void dribbling.

Recurrent UTI.

Therefore the mechanism of frequency is often:

Incomplete bladder emptying.

5. Neurological Causes

Neurological disorders can interfere with normal control of:

Bladder storage and emptying.

This may produce:

Frequency.

Urgency.

Urge incontinence.

Retention, depending on the site and type of neurological lesion.

6. Multiple Sclerosis

The original notes correctly include:

Multiple sclerosis – MS.

MS can disrupt the neural pathways controlling the bladder.

A common pattern is:

Neurogenic detrusor overactivity.

This causes:

Frequency.

Urgency.

Nocturia.

Urge incontinence.

Other Neurogenic Bladder Patterns

Neurological disease may also cause:

Impaired bladder contraction.

Detrusor-sphincter dyssynergia.

These can produce:

Incomplete emptying

or even:

Urinary retention.

So neurological bladder disease can produce both storage and voiding symptoms.

7. Other Neurological Causes

Other neurological causes of urinary frequency or neurogenic bladder include:

Spinal cord lesions.

Parkinson disease.

Stroke.

Diabetic autonomic neuropathy.

Cauda equina or spinal disease.

The exact urinary pattern depends on the level and nature of the lesion.

8. Overactive Bladder

An important additional cause is:

Overactive bladder.

This is characterised by:

Urinary urgency, usually with:

Frequency.

Nocturia.

It may occur:

With or without urge incontinence.

It is diagnosed when these symptoms are not better explained by infection or another obvious pathology.

9. Bladder Irritation

Any process that irritates the bladder can increase urinary frequency.

Examples include:

Cystitis.

Bladder stones.

Bladder tumour.

Radiation cystitis.

Interstitial cystitis / bladder pain syndrome.

These conditions make the bladder feel full before it actually contains a large volume.

10. Bladder Stones

Bladder calculi can cause:

Frequency.

Urgency.

Dysuria.

Haematuria.

Symptoms may sometimes vary with:

Position or movement.

They are particularly likely when there is underlying:

Bladder outlet obstruction.

11. Pregnancy

Pregnancy is another common physiological cause of urinary frequency.

Early in pregnancy, hormonal and haemodynamic changes increase:

Renal blood flow and urine production.

Later, the enlarging uterus can compress the:

Bladder.

Therefore urinary frequency is common even without infection.

12. Anxiety

Anxiety can increase the sensation of needing to urinate and may produce:

Frequent small-volume voiding.

This is usually a diagnosis considered only after organic causes have been assessed.

13. Caffeine and Other Bladder Irritants

Caffeine can increase urinary frequency through:

Mild diuretic effects

and

Bladder stimulation.

Common sources include:

Coffee.

Tea.

Energy drinks.

Some carbonated drinks and alcohol may also worsen urgency or frequency in susceptible people.

14. Frequency Versus Polyuria

This distinction is particularly important.

Urinary frequency:

The patient urinates often, usually passing:

Small amounts each time.

Polyuria:

The patient produces an abnormally large:

Total urine volume.

In adults this is often approximately:

More than 3 litres per day, although clinical interpretation depends on body size and context.

15. Causes of Polyuria

Conditions causing polyuria may be perceived by the patient as “frequency.”

Important causes include:

Diabetes mellitus.

Diabetes insipidus.

Primary polydipsia.

Diuretic therapy.

Hypercalcaemia.

Therefore it is useful to ask:

Are they passing small amounts frequently, or genuinely producing a large volume of urine?

16. Diabetes Mellitus

Hyperglycaemia can exceed the renal threshold for glucose reabsorption.

Glucose then appears in the urine and causes:

Osmotic diuresis.

This produces:

Polyuria

and often:

Polydipsia.

The patient may describe this simply as urinary frequency.

17. Diabetes Insipidus

Diabetes insipidus causes impaired ability to concentrate urine because of:

ADH deficiency

or

Renal resistance to ADH.

This results in:

Large volumes of dilute urine.

Therefore the key finding is:

Polyuria rather than true small-volume frequency.

18. Nocturia

Nocturia means waking from sleep to pass urine.

It commonly accompanies urinary frequency in:

BPH.

Overactive bladder.

Heart failure.

Diabetes mellitus.

Sleep disorders.

Excess evening fluid intake.

Nocturia can therefore provide additional clues to the underlying cause.

19. Storage Symptoms

Urinary symptoms can be divided into:

Storage symptoms

and

Voiding symptoms.

Storage symptoms include:

Frequency.

Urgency.

Nocturia.

Urge incontinence.

20. Voiding Symptoms

Voiding symptoms include:

Hesitancy.

Weak stream.

Intermittency.

Straining.

Incomplete emptying.

This distinction is particularly useful when evaluating:

BPH or urethral obstruction.

21. Infection Causes – Note Form

Cystitis:

Frequency + urgency + dysuria.

Urethritis:

Frequency + dysuria ± urethral discharge.

Prostatitis:

Frequency + dysuria + pelvic/perineal discomfort ± fever.

22. Obstructive Causes – Note Form

BPH:

Frequency + nocturia + weak stream + hesitancy + incomplete emptying.

Urethral stricture:

Frequency + weak stream + straining + incomplete emptying.

Bladder outlet obstruction:

Residual urine causes the bladder to fill again more quickly.

23. Bladder Causes – Note Form

Bladder tumour:

Frequency/urgency may occur.

Painless haematuria remains the major warning feature.

Bladder stones:

Frequency + dysuria + haematuria.

Overactive bladder:

Urgency + frequency ± urge incontinence.

Interstitial cystitis/bladder pain syndrome:

Frequency + urgency + bladder/pelvic pain, usually without conventional bacterial infection.

24. Neurological Causes – Note Form

Multiple sclerosis:

Neurogenic detrusor overactivity → frequency + urgency + urge incontinence.

Spinal cord disease:

May cause storage or voiding dysfunction.

Parkinson disease/stroke:

Can cause urgency and frequency.

Autonomic neuropathy:

May cause abnormal bladder emptying and residual urine.

25. Important Corrections and Additions

The original term:

“Prostatic hypertrophy”

is usually better written as:

BENIGN PROSTATIC HYPERPLASIA – BPH.

A bladder tumour may cause frequency, but the classic presenting feature is:

PAINLESS VISIBLE HAEMATURIA.

An important missing category is:

OVERACTIVE BLADDER, which is a common cause of frequency and urgency.

Also remember to distinguish true urinary frequency from:

POLYURIA.

Diabetes mellitus and diabetes insipidus mainly cause:

INCREASED TOTAL URINE VOLUME, rather than bladder irritation.

Key Clinical Pattern

FREQUENCY + DYSURIA + URGENCY → CYSTITIS/UTI.

FREQUENCY + URETHRAL DISCHARGE → URETHRITIS.

FREQUENCY + PERINEAL PAIN/FEVER → PROSTATITIS.

FREQUENCY + WEAK STREAM + HESITANCY + NOCTURIA → BPH OR OUTLET OBSTRUCTION.

FREQUENCY + URGENCY ± URGE INCONTINENCE → OVERACTIVE/NEUROGENIC BLADDER.

FREQUENCY + HAEMATURIA → CONSIDER STONE, INFECTION OR BLADDER TUMOUR.

LARGE-VOLUME FREQUENT URINATION + THIRST → THINK POLYURIA, ESPECIALLY DIABETES MELLITUS OR DIABETES INSIPIDUS.

Medicine – Causes of Haematuria

Haematuria means the presence of red blood cells in the urine. It may be visible (macroscopic/gross) or detected only on testing as microscopic haematuria.

The most useful first distinction is whether the bleeding is:

Glomerular — arising from the renal glomeruli.

or

Non-glomerular — arising from the renal pelvis, ureter, bladder, prostate, urethra or other urinary structures.

1. Urinary Tract Infection

A urinary tract infection is a common cause of haematuria.

Inflammation of the urinary mucosa can cause:

Microscopic or visible blood in the urine.

Typical associated symptoms include:

Dysuria.

Frequency.

Urgency.

Suprapubic discomfort.

Pyelonephritis

If infection involves the kidney, patients may develop:

Fever.

Flank pain.

Pyuria.

Bacteriuria.

WBC casts.

Haematuria may also occur.

2. Urinary Tract Malignancy

An important cause of haematuria is:

Urinary tract malignancy.

Examples include:

Bladder cancer.

Renal cell carcinoma.

Upper urinary tract urothelial carcinoma.

Painless Visible Haematuria

A classic warning feature is:

Painless visible haematuria.

This should prompt evaluation for:

Urinary tract malignancy, especially in older adults or patients with relevant risk factors such as smoking.

Therefore:

PAINLESS VISIBLE HAEMATURIA → EXCLUDE URINARY TRACT CANCER.

3. Renal Calculi

Kidney and ureteric stones commonly produce:

Haematuria.

This may be microscopic or visible.

Typical associated symptoms include:

Severe colicky loin-to-groin pain.

Restlessness.

Nausea or vomiting.

Mechanism

A calculus damages or irritates the urinary epithelium as it moves through the urinary tract.

This causes:

Local bleeding

and therefore:

Haematuria.

4. Acute Glomerulonephritis

Acute glomerulonephritis produces:

Glomerular haematuria.

The urine may appear:

Tea-coloured or cola-coloured.

Other typical findings include:

Proteinuria.

Dysmorphic RBCs.

Red-cell casts.

Hypertension.

Reduced GFR.

5. Glomerular Versus Non-Glomerular Haematuria

Glomerular haematuria tends to be associated with:

Dysmorphic RBCs.

Acanthocytes.

RBC casts.

Proteinuria.

Non-glomerular haematuria is more likely to show:

Uniform RBCs.

Blood clots.

Little or no significant proteinuria.

This distinction is very useful clinically.

6. IgA Nephropathy

IgA nephropathy is an important glomerular cause of haematuria.

A classic presentation is:

Visible haematuria during or within a few days of an upper respiratory infection.

This is known as:

Synpharyngitic haematuria.

IgA Nephropathy Pattern

The timing is important:

Upper respiratory infection

↓

Haematuria occurs immediately or within days

↓

Think IgA nephropathy.

This contrasts with post-streptococcal GN, where haematuria usually follows the infection after a latent interval.

7. Interstitial Nephritis

Acute interstitial nephritis – AIN can cause:

Microscopic haematuria.

However, more characteristic findings include:

Sterile pyuria.

WBC casts.

Mild-to-moderate proteinuria.

AKI.

Drug-Induced AIN

AIN is often associated with medications such as:

Antibiotics.

NSAIDs.

Proton-pump inhibitors.

Haematuria can occur but is usually not the dominant feature.

8. Polycystic Kidney Disease

Autosomal dominant polycystic kidney disease – ADPKD can cause haematuria.

This may result from:

Cyst rupture.

Bleeding into a cyst.

Urinary infection.

Associated renal calculi.

ADPKD Clues

Other features may include:

Hypertension.

Bilateral enlarged cystic kidneys.

Flank or abdominal pain.

Family history of kidney disease.

9. Renal Papillary Necrosis

Renal papillary necrosis involves ischaemic destruction of the renal papillae.

It can produce:

Haematuria.

Flank pain.

Passage of sloughed papillary tissue.

Urinary obstruction.

Causes of Papillary Necrosis

Important associations include:

Diabetes mellitus.

Analgesic/NSAID exposure.

Sickle cell disease or trait.

Severe pyelonephritis.

Urinary tract obstruction.

A traditional mnemonic is based around these major causes.

10. Hypertension

Severe hypertension can produce haematuria through:

Renal vascular and glomerular injury.

This is particularly relevant in:

Hypertensive emergency or accelerated hypertension.

Associated findings may include:

Proteinuria.

AKI.

Retinopathy.

Chronic Hypertension

Uncomplicated chronic hypertension is more commonly associated with:

Low-grade proteinuria

than prominent haematuria.

Therefore marked haematuria should prompt consideration of another renal or urinary cause.

11. Endometriosis

Endometriosis can rarely involve the:

Bladder or urinary tract.

If bladder endometriosis is present, the patient may develop:

Cyclical haematuria.

This means haematuria occurs in association with:

Menstruation.

Clinical Clue

Therefore:

HAEMATURIA RECURRING WITH MENSTRUATION → CONSIDER URINARY TRACT ENDOMETRIOSIS.

However, menstrual contamination of the urine specimen should also be excluded.

12. Factitious Haematuria

The older term:

Fictitious haematuria

usually refers to deliberately produced or falsely reported haematuria.

A more appropriate term is:

Factitious haematuria.

Possible mechanisms include deliberate contamination of the urine sample with:

Blood.

Important Approach

Factitious haematuria should only be considered after appropriate investigation and when the findings are inconsistent.

It is important not to assume a factitious cause before excluding genuine urinary disease.

13. Menstrual Contamination

An important common cause of apparent haematuria is:

Menstrual contamination.

Blood may enter the urine specimen during collection.

If this is suspected, urine testing can be repeated:

After menstruation

using a properly collected specimen.

14. Trauma

Trauma can produce haematuria by injuring:

Kidney.

Ureter.

Bladder.

Urethra.

Examples include:

Blunt abdominal trauma.

Pelvic fracture.

Instrumentation.

15. Anticoagulant Therapy

Anticoagulants can make urinary tract bleeding more likely or more obvious.

However:

Anticoagulation should not automatically be accepted as the sole explanation for haematuria.

An underlying lesion, including malignancy, may still be present and should be investigated appropriately.

16. Exercise-Induced Haematuria

Strenuous exercise can cause:

Transient microscopic or visible haematuria.

This usually resolves after exercise stops.

Persistent haematuria requires further evaluation.

17. Sickle Cell Disease and Trait

Sickle cell disease and sickle cell trait can cause haematuria through:

Renal medullary ischaemia.

They are also associated with:

Papillary necrosis.

18. Benign Prostatic Disease

In men, prostate disorders can produce haematuria.

Examples include:

Benign prostatic enlargement.

Prostatitis.

Prostate malignancy.

The urinary symptoms and patient age help guide further investigation.

19. Glomerular Haematuria – Note Form

Acute GN:

Tea/cola-coloured urine.

Dysmorphic RBCs.

RBC casts.

Proteinuria.

IgA nephropathy:

Haematuria during or soon after an upper respiratory infection.

Other glomerular diseases:

Lupus nephritis.

ANCA-associated GN.

Anti-GBM disease.

Post-infectious GN.

20. Non-Glomerular Haematuria – Note Form

UTI:

Haematuria + pyuria + dysuria.

Calculi:

Haematuria + severe colicky pain.

Urinary malignancy:

Often painless visible haematuria.

ADPKD:

Cyst bleeding/rupture ± stones/infection.

Papillary necrosis:

Diabetes, analgesics/NSAIDs, sickling disorders and severe infection.

Endometriosis:

Cyclical haematuria associated with menstruation.

21. Urine Dipstick and Microscopy

A urine dipstick detects:

Haem pigment.

Therefore a positive blood result can be caused by:

Intact RBCs.

Haemoglobin.

Myoglobin.

Microscopy helps distinguish them.

Interpretation

Dipstick positive + RBCs present → haematuria.

Dipstick positive + few/no RBCs → think myoglobinuria or haemoglobinuria.

This is particularly important in:

Rhabdomyolysis

and

Intravascular haemolysis.

22. Red Cell Morphology

Red-cell morphology may help determine the source of haematuria.

Dysmorphic RBCs, particularly:

Acanthocytes,

suggest passage through an abnormal glomerular filtration barrier.

Therefore they support:

Glomerular haematuria.

23. Red Cell Casts

The presence of:

RBC casts

is particularly important.

Because casts form within renal tubules, RBC casts indicate bleeding originating within:

The kidney.

The major association is:

Glomerulonephritis.

24. Blood Clots

Visible blood clots usually suggest:

Non-glomerular bleeding.

This is because glomerular bleeding generally produces altered RBCs rather than large clots.

Therefore:

HAEMATURIA + CLOTS → THINK UROLOGICAL SOURCE.

25. Haematuria with Proteinuria

The combination:

Haematuria + significant proteinuria

raises suspicion of:

Glomerular disease.

This becomes even stronger if there are:

Dysmorphic RBCs.

RBC casts.

Reduced renal function.

26. Haematuria with Pain

Painful haematuria suggests causes such as:

Calculi.

UTI.

Pyelonephritis.

Trauma.

27. Painless Haematuria

Painless visible haematuria is particularly concerning for:

Urinary tract malignancy.

Therefore it should not be ignored even if it occurs only once.

28. Important Corrections to the Original Notes

Hypertension can cause haematuria, particularly when severe, but uncomplicated chronic hypertension is not one of the strongest causes of prominent haematuria.

Interstitial nephritis may produce microscopic haematuria, but the more characteristic urinary findings are:

STERILE PYURIA + WBC CASTS ± MILD PROTEINURIA.

The older term:

“Fictitious haematuria”

is better described as:

FACTITIOUS HAEMATURIA.

It should only be considered after genuine renal and urinary causes have been appropriately assessed.

An important additional cause is:

MENSTRUAL CONTAMINATION, which can mimic haematuria.

Other useful additions include:

Trauma.

Exercise.

Sickle cell disease/trait.

Prostatic disease.

Anticoagulant-associated bleeding, while still investigating for an underlying cause.

Key Clinical Pattern

For exams and clinical reasoning, remember:

HAEMATURIA + DYSURIA/PYURIA → UTI.

HAEMATURIA + SEVERE COLICKY PAIN → CALCULUS.

PAINLESS VISIBLE HAEMATURIA → EXCLUDE URINARY TRACT MALIGNANCY.

TEA/COLA URINE + PROTEINURIA + RBC CASTS → GLOMERULONEPHRITIS.

HAEMATURIA DURING/IMMEDIATELY AFTER URI → IgA NEPHROPATHY.

CYCLICAL HAEMATURIA WITH MENSTRUATION → CONSIDER URINARY ENDOMETRIOSIS.

HAEMATURIA + RBC CASTS/DYSMORPHIC RBCs → GLOMERULAR SOURCE.

HAEMATURIA + CLOTS → MORE LIKELY UROLOGICAL/NON-GLOMERULAR SOURCE.

Medicine – Causes of Coloured Urine

Abnormal urine colour can result from blood, pigments, bilirubin, medications, foods, metabolic disorders or muscle breakdown. The colour itself may provide a useful diagnostic clue, but it should always be interpreted together with urinalysis, microscopy and the clinical context.

A practical way to approach coloured urine is to ask whether the colour is due to:

Blood.

Bilirubin.

Myoglobin.

Drugs or food pigments.

Metabolic pigments.

1. Haematuria

Haematuria means the presence of red blood cells in the urine.

Urine may appear:

Pink.

Red.

Brown.

Tea-coloured or cola-coloured.

The appearance depends on the amount and source of bleeding.

2. Glomerular Haematuria

When bleeding originates from the glomeruli, urine may appear:

Tea-coloured or cola-coloured.

This occurs because red blood cells become altered while passing through the nephron.

Typical associated findings include:

Dysmorphic RBCs.

Red-cell casts.

Proteinuria.

This pattern suggests:

Glomerulonephritis.

3. Non-Glomerular Haematuria

Bleeding from the urinary tract may produce:

Bright red or pink urine.

Possible causes include:

UTI.

Renal or ureteric calculi.

Urinary tract tumour.

Trauma.

Prostatic disease.

Clots, when present, generally favour:

Non-glomerular urinary tract bleeding.

4. Obstructive Jaundice

The original notes correctly include:

Obstructive jaundice.

In biliary obstruction, conjugated bilirubin accumulates in the blood.

Because conjugated bilirubin is:

Water-soluble,

it can be excreted in urine.

This produces:

Dark brown or tea-coloured urine.

5. Bilirubinuria

Urinary bilirubin indicates:

Conjugated hyperbilirubinaemia.

It may occur in:

Extrahepatic biliary obstruction.

Cholestatic liver disease.

Hepatocellular disease with conjugated bilirubin elevation.

Therefore dark urine is not limited specifically to obstructive jaundice.

6. Obstructive Jaundice Pattern

A typical pattern is:

Dark urine.

Pale stools.

Jaundice.

Pruritus.

The dark urine results from:

Conjugated bilirubin excretion.

The pale stools result from reduced delivery of:

Bile pigments to the intestine.

7. Drugs

Many medications can alter urine colour without causing urinary tract disease.

The classic example in the original notes is:

Rifampicin.

8. Rifampicin

Rifampicin can cause an:

Orange-red discoloration

of body fluids, including:

Urine.

Tears.

Sweat.

Saliva.

This is usually harmless.

Therefore:

RIFAMPICIN → ORANGE/RED URINE.

9. Other Drug-Related Urine Colours

Other medications can also alter urine colour.

Examples include:

Phenazopyridine → orange urine.

Metronidazole → dark or reddish-brown urine in some patients.

Nitrofurantoin → brownish urine.

Some laxatives containing senna → reddish or brown urine.

The exact colour varies with the drug and concentration.

10. Myoglobinuria

Myoglobinuria occurs when large amounts of myoglobin are released from damaged skeletal muscle.

The classic cause is:

Rhabdomyolysis.

Urine may appear:

Dark brown, red-brown or cola-coloured.

11. Myoglobinuria and Dipstick Testing

Urine dipsticks detect the haem component of:

Haemoglobin and myoglobin

as well as intact RBCs.

Therefore myoglobinuria produces:

Positive dipstick for “blood”

but urine microscopy shows:

Few or no red blood cells.

This is an important diagnostic clue.

12. Rhabdomyolysis Pattern

Think of rhabdomyolysis when dark urine is associated with:

Muscle pain.

Muscle weakness.

Very high CK.

Hyperkalaemia.

AKI.

Therefore:

DARK URINE + POSITIVE BLOOD DIPSTICK + FEW/NO RBCs → THINK MYOGLOBINURIA.

13. Haemoglobinuria

Another important cause of dark urine is:

Haemoglobinuria.

This occurs during significant:

Intravascular haemolysis.

Like myoglobinuria, the urine dipstick is positive for blood but microscopy may show:

Few or no RBCs.

14. Distinguishing Haematuria from Pigmenturia

A useful pattern is:

Dipstick positive for blood + many RBCs on microscopy → haematuria.

Dipstick positive for blood + few/no RBCs → myoglobinuria or haemoglobinuria.

This is one of the most useful clinical distinctions in coloured urine.

15. Beetroot

Eating beetroot can cause:

Red or pink urine.

This is known as:

Beeturia.

It is benign and does not indicate haematuria.

16. Beeturia

Beeturia may be mistaken for:

Blood in the urine.

A urine dipstick and microscopy can clarify the difference.

In beeturia:

Red colour is present

but there are no corresponding urinary red cells.

17. Porphyria

Certain porphyrias can produce urine that becomes:

Red, reddish-brown or port-wine coloured.

The colour may become more obvious after the urine stands or is exposed to:

Light and air.

18. Acute Porphyrias

Acute hepatic porphyrias may present with:

Severe abdominal pain.

Neurological symptoms.

Autonomic disturbance.

Psychiatric symptoms.

The urine may darken because of increased:

Porphyrin precursors and porphyrin pigments.

19. Alkaptonuria

Alkaptonuria is a rare inherited disorder of tyrosine metabolism caused by deficiency of:

Homogentisate 1,2-dioxygenase.

This leads to accumulation of:

Homogentisic acid.

20. Urine in Alkaptonuria

Fresh urine may initially appear relatively normal.

When exposed to:

Air,

homogentisic acid oxidises and polymerises.

The urine gradually turns:

Dark brown or black.

Therefore:

ALKAPTONURIA → URINE DARKENS ON STANDING.

21. Other Features of Alkaptonuria

Over time, homogentisic acid deposits in connective tissues, producing:

Ochronosis.

Patients may develop:

Bluish-black pigmentation of cartilage.

Degenerative arthritis.

Spinal disease.

22. Dark Urine in Dehydration

An important common cause not listed originally is:

Concentrated urine from dehydration.

Urine becomes:

Dark yellow or amber.

This results from increased concentration of normal urinary pigments rather than pathological blood or bilirubin.

23. Cloudy or Milky Urine

Although not strictly “coloured” urine, urine may appear cloudy or milky because of:

Pyuria.

Crystals.

Phosphaturia.

Chyluria.

Therefore appearance alone is not enough to determine the cause.

24. Red or Pink Urine – Note Form

Haematuria:

UTI.

Calculi.

GN.

Tumour.

Trauma.

Beetroot:

Benign beeturia.

Rifampicin:

Orange-red discoloration.

Porphyria:

Red to reddish-brown urine.

May darken on standing.

25. Brown or Cola-Coloured Urine – Note Form

Glomerular haematuria:

Tea/cola-coloured urine.

Myoglobinuria:

Rhabdomyolysis.

Dipstick positive for blood with few/no RBCs.

Haemoglobinuria:

Intravascular haemolysis.

Dipstick positive with few/no RBCs.

Bilirubinuria:

Conjugated hyperbilirubinaemia.

Dark tea/brown urine.

26. Orange Urine – Note Form

Rifampicin:

Classic orange-red urine.

Phenazopyridine:

Orange urine.

Concentrated urine:

Dark yellow/orange appearance may occur with dehydration.

27. Black Urine – Note Form

Alkaptonuria:

Urine becomes dark brown/black after standing.

Some porphyrias may also produce very dark urine.

28. Important Corrections to the Original Notes

Obstructive jaundice causes dark urine because of:

CONJUGATED BILIRUBINURIA.

However, conjugated bilirubin can also appear in urine in other hepatobiliary disorders, so dark urine is not exclusive to mechanical obstruction.

Myoglobinuria should be distinguished from haematuria by:

DIPSTICK POSITIVE FOR BLOOD + FEW OR NO RBCs ON MICROSCOPY.

An important additional differential is:

HAEMOGLOBINURIA FROM INTRAVASCULAR HAEMOLYSIS.

It gives the same dipstick pattern as myoglobinuria.

Beetroot causes benign red urine and should not be confused with true haematuria.

Alkaptonuria classically causes:

URINE THAT DARKENS ON STANDING OR EXPOSURE TO AIR.

Key Clinical Pattern

Remember the colour associations:

RED/PINK → HAEMATURIA, BEETROOT, RIFAMPICIN.

TEA/COLA → GLOMERULAR HAEMATURIA, MYOGLOBIN, HAEMOGLOBIN.

DARK BROWN → CONJUGATED BILIRUBIN.

ORANGE-RED → RIFAMPICIN.

RED-BROWN/PORT-WINE → PORPHYRIA.

BLACK ON STANDING → ALKAPTONURIA.

And the most useful investigation clue is:

DIPSTICK “BLOOD” + RBCs ON MICROSCOPY → HAEMATURIA.

DIPSTICK “BLOOD” + FEW/NO RBCs → MYOGLOBINURIA OR HAEMOGLOBINURIA.

Medicine – Urea and Creatinine

Urea and creatinine are commonly measured blood markers used to assess kidney function, but neither is a perfect measure of glomerular filtration on its own. Their interpretation depends on factors such as muscle mass, hydration, protein intake, liver function, drugs and pregnancy.

A useful distinction is that creatinine is strongly influenced by muscle metabolism, whereas urea is strongly influenced by protein metabolism, hydration and liver function.

1. Creatinine

Creatinine is produced from the breakdown of:

Creatine in skeletal muscle.

It is released into the blood at a relatively steady rate and is eliminated mainly by:

Glomerular filtration.

A small amount is also:

Secreted by the proximal tubule.

Because of this, serum creatinine is commonly used as a marker of renal filtration.

2. Raised Creatinine – Reduced GFR

The most important cause of a raised creatinine is:

Reduced glomerular filtration rate.

This may occur in:

Acute kidney injury.

Chronic kidney disease.

Pre-renal hypoperfusion.

Intrinsic renal disease.

Post-renal obstruction.

Therefore:

RISING CREATININE → THINK REDUCED GFR FIRST.

3. Renal Failure

The older term:

Renal failure

is now usually replaced by more specific terminology such as:

Acute kidney injury – AKI

or

Chronic kidney disease – CKD.

In both situations, impaired filtration reduces creatinine clearance and causes:

Serum creatinine to rise.

4. Creatinine in Acute Kidney Injury

In AKI, creatinine does not always rise immediately after GFR falls.

There can be a delay before the blood level reaches a new steady state.

Therefore in rapidly evolving AKI:

Serum creatinine may underestimate the immediate severity of renal dysfunction.

This is why urine output and serial measurements are also important.

5. Large Muscle Bulk

The original notes correctly include:

Large muscle bulk.

People with greater skeletal muscle mass produce more creatinine.

Therefore a muscular person may have:

A relatively high baseline serum creatinine

despite normal renal function.

6. Rhabdomyolysis

Rhabdomyolysis causes extensive skeletal muscle breakdown.

This releases:

Myoglobin.

Potassium.

Phosphate.

Creatine and related metabolites.

Creatinine may rise because of:

Increased muscle breakdown

and, importantly,

AKI caused by pigment-associated tubular injury.

7. Rhabdomyolysis Pattern

Typical associated findings include:

Very high CK.

Dark urine.

Urine dipstick positive for blood with few or no RBCs.

Hyperkalaemia.

Hyperphosphataemia.

AKI.

Therefore:

RHABDOMYOLYSIS + RISING CREATININE → THINK BOTH MUSCLE BREAKDOWN AND RENAL INJURY.

8. Tubular Secretion of Creatinine

Although most creatinine is filtered by the glomerulus, a small amount is:

Secreted by proximal tubular cells.

Some drugs inhibit this secretion.

As a result:

Serum creatinine rises even though true GFR may remain unchanged.

9. Trimethoprim

The classic example is:

Trimethoprim.

Trimethoprim inhibits proximal tubular secretion of creatinine.

This can produce:

A modest increase in serum creatinine without a true reduction in GFR.

This is sometimes described as a:

Pseudo-rise in creatinine.

10. Cimetidine

Another classic drug that reduces tubular creatinine secretion is:

Cimetidine.

Therefore:

TRIMETHOPRIM OR CIMETIDINE → CREATININE MAY RISE WITHOUT TRUE RENAL DETERIORATION.

11. Potassium-Sparing Diuretics

The original notes state that:

Potassium-sparing diuretics

reduce tubular creatinine secretion.

This is too broad.

Some agents may influence creatinine handling, but not all potassium-sparing diuretics raise creatinine through the same mechanism.

A better high-yield association is:

Trimethoprim and cimetidine → inhibit tubular creatinine secretion.

Potassium-sparing drugs may also increase creatinine because of:

Haemodynamic effects

or underlying renal impairment.

12. Reduced Creatinine

A low serum creatinine usually reflects:

Reduced creatinine production

or

Increased renal clearance.

The most common cause is:

Low muscle mass.

13. Small Muscle Mass

Low muscle mass reduces creatinine production.

This occurs in:

Frailty.

Malnutrition.

Cachexia.

Muscle wasting disorders.

Amputation.

Advanced age.

Therefore:

A normal or low creatinine does not always mean normal kidney function.

14. Clinical Importance of Low Muscle Mass

A patient with severe muscle wasting may have:

Significant kidney dysfunction

while serum creatinine remains only mildly elevated or even apparently normal.

This is an important limitation of creatinine-based assessment.

15. Pregnancy and Low Creatinine

The original notes correctly include:

Pregnancy.

During pregnancy:

Renal plasma flow increases

and

GFR increases.

This increases creatinine clearance and lowers:

Serum creatinine.

16. Clinical Importance in Pregnancy

Because normal creatinine is lower during pregnancy, a value that would look normal in a non-pregnant adult may represent:

Abnormal renal function in pregnancy.

Therefore changes in creatinine during pregnancy should be interpreted carefully.

17. SIADH and Creatinine

The original notes include:

SIADH

as a cause of low creatinine.

This is not a strong or classic association.

SIADH mainly causes:

Water retention and dilutional hyponatraemia.

Serum urea and uric acid are more characteristically reduced.

Creatinine may occasionally be mildly diluted, but:

LOW CREATININE IS NOT A KEY DIAGNOSTIC FEATURE OF SIADH.

18. Urea

Urea is produced in the:

Liver.

It is formed through the urea cycle from nitrogen generated during:

Protein metabolism.

It is then excreted mainly through the:

Kidneys.

19. Urea Is Less Specific Than Creatinine

Serum urea is affected by many factors other than renal filtration.

These include:

Hydration.

Protein intake.

GI bleeding.

Catabolism.

Liver function.

Pregnancy.

For this reason:

UREA IS LESS SPECIFIC FOR GFR THAN CREATININE.

20. Raised Urea – Reduced GFR

Reduced renal filtration causes:

Reduced urea excretion.

Therefore urea rises in:

AKI.

CKD.

However, an elevated urea does not automatically mean intrinsic kidney disease because many non-renal factors can also raise it.

21. Dehydration

The original notes correctly include:

Dehydration.

In volume depletion, renal blood flow decreases and the kidney increases:

Sodium and water reabsorption.

Urea is also reabsorbed more extensively.

As a result:

Urea may rise disproportionately compared with creatinine.

22. Pre-Renal AKI

In a classic pre-renal state:

Urea reabsorption increases.

Creatinine is not reabsorbed to the same degree.

Therefore the:

Urea-to-creatinine ratio

may increase.

This pattern can support a diagnosis of:

Pre-renal hypoperfusion.

However, it is not perfectly specific.

23. Diuretics

The original notes include:

Diuretics.

Diuretics generally raise urea indirectly rather than directly.

Excessive diuresis can cause:

Volume depletion.

This produces:

Pre-renal hypoperfusion

and therefore:

Raised urea ± raised creatinine.

24. Gastrointestinal Bleeding

The original notes correctly include:

GI bleeding.

This is particularly important in:

Upper GI bleeding.

Blood in the gastrointestinal tract is digested as a:

Protein load.

The absorbed amino acids are then metabolised by the liver, increasing:

Urea production.

25. Urea in Upper GI Bleeding

Therefore:

UPPER GI BLEED → DIGESTED BLOOD → INCREASED PROTEIN LOAD → ↑ UREA.

A disproportionately high urea relative to creatinine may therefore suggest:

Upper GI bleeding, especially in the right clinical context.

26. Corticosteroids

Corticosteroids increase:

Protein catabolism.

This releases more amino acids for hepatic metabolism, increasing:

Urea production.

Therefore corticosteroids can cause:

Raised serum urea.

27. Tetracyclines

Some older tetracyclines have an:

Anti-anabolic effect

and can increase protein breakdown.

This may raise:

Serum urea.

However, this is an older association and is less emphasised in modern clinical practice.

28. High-Protein Diet

A high-protein diet increases:

Nitrogen intake.

More nitrogen is converted into:

Urea.

Therefore serum urea may rise even if renal function is normal.

29. Increased Catabolism

Any state with increased protein breakdown may raise urea.

Examples include:

Sepsis.

Major trauma.

Burns.

Severe infection.

Postoperative states.

Other hypercatabolic illnesses.

30. Reduced Urea

Low serum urea usually reflects:

Reduced urea production

or

Increased clearance/dilution.

Important causes include:

Severe liver disease.

Low protein intake.

SIADH.

Pregnancy.

31. Chronic Liver Disease

The original notes correctly include:

Chronic liver disease.

The liver is responsible for converting ammonia into:

Urea.

When hepatic function is severely impaired:

Urea synthesis falls.

Therefore serum urea may be low.

32. Severe Liver Failure

A useful pattern is:

Severe liver dysfunction → reduced urea synthesis → low serum urea.

At the same time, ammonia may rise because hepatic detoxification is impaired.

33. Starvation

Starvation reduces:

Protein intake.

This decreases the amount of nitrogen available for:

Urea production.

Therefore serum urea may be low.

34. Anabolic State

During an anabolic state, amino acids are preferentially used for:

Protein synthesis

rather than being broken down.

Therefore less nitrogen is converted into urea.

This may result in:

Reduced serum urea.

35. Alcohol Abuse

The original notes include:

Alcohol abuse.

Alcohol itself does not necessarily directly lower urea.

Low urea in chronic alcohol misuse more often reflects:

Poor nutrition.

Low protein intake.

Chronic liver disease.

Therefore the relationship is usually indirect.

36. SIADH and Low Urea

The original notes correctly include:

SIADH.

SIADH causes:

Excess water retention.

This leads to:

Dilutional hyponatraemia.

Serum urea is often reduced because of:

Dilution and altered renal handling of urea.

37. Typical SIADH Pattern

Typical laboratory features include:

Low serum sodium.

Low serum osmolality.

Inappropriately concentrated urine.

Urine sodium that is not suppressed.

Low serum uric acid.

Often low serum urea.

Therefore:

LOW UREA IS A SUPPORTIVE FEATURE OF SIADH.

38. Pregnancy and Low Urea

Pregnancy lowers urea because:

GFR increases.

This increases renal urea clearance.

In addition, nitrogen is increasingly used for:

Maternal and fetal tissue growth.

Therefore both urea and creatinine are commonly lower in normal pregnancy.

39. Urea and Creatinine in Pre-Renal AKI

In pre-renal AKI:

Urea often rises more than creatinine.

This occurs because:

Urea is reabsorbed with water

while creatinine is not significantly reabsorbed.

Therefore:

DISPROPORTIONATELY HIGH UREA → CONSIDER PRE-RENAL HYPOPERFUSION.

40. Urea and Creatinine in Acute Tubular Injury

In acute tubular injury:

Tubular function is impaired.

Urea reabsorption becomes less effective.

Therefore the disproportionate rise in urea seen in classic pre-renal states may be less marked.

However, these patterns overlap and should not be used alone to make the diagnosis.

41. Creatinine and eGFR

Serum creatinine is used in equations to estimate:

Glomerular filtration rate – eGFR.

The reliability of creatinine-based eGFR depends partly on normal relationships between:

Muscle mass and creatinine production.

42. When eGFR May Be Misleading

Creatinine-based eGFR may be less accurate in people with:

Very high muscle mass.

Very low muscle mass.

Severe malnutrition.

Amputation.

Rapidly changing renal function.

43. eGFR in Acute Kidney Injury

A particularly important point is:

eGFR is unreliable during rapidly changing AKI.

This is because serum creatinine is not in a:

Steady state.

Therefore AKI should be assessed using:

Serial creatinine measurements + urine output + clinical context.

44. Raised Creatinine – Note Form

Reduced GFR:

AKI.

CKD.

Pre-renal hypoperfusion.

Intrinsic renal disease.

Post-renal obstruction.

Large muscle bulk:

Higher baseline creatinine production.

Rhabdomyolysis:

Muscle breakdown plus possible pigment-induced AKI.

Reduced tubular creatinine secretion:

Trimethoprim.

Cimetidine.

May increase serum creatinine without true reduction in GFR.

45. Reduced Creatinine – Note Form

Small muscle mass:

Frailty.

Malnutrition.

Cachexia.

Muscle wasting.

Pregnancy:

Increased GFR and creatinine clearance.

SIADH:

May cause mild dilution, but low creatinine is not a characteristic diagnostic feature.

46. Raised Urea – Note Form

Reduced GFR:

AKI.

CKD.

Dehydration:

Reduced renal perfusion + increased urea reabsorption.

Diuretics:

May cause volume depletion and pre-renal azotaemia.

GI bleeding:

Digested blood acts as a protein load.

Especially characteristic of upper GI bleeding.

Corticosteroids:

Increase protein catabolism.

Tetracyclines:

Some older agents increase catabolism; less important in modern practice.

High-protein diet:

Increased nitrogen load.

Increased catabolism:

Sepsis.

Burns.

Trauma.

Severe illness.

47. Reduced Urea – Note Form

Chronic/severe liver disease:

Reduced hepatic urea production.

Starvation:

Reduced protein intake.

Anabolic state:

Reduced protein breakdown.

Alcohol misuse:

Usually through malnutrition or chronic liver disease.

SIADH:

Dilution and increased renal urea handling.

Pregnancy:

Increased GFR and increased nitrogen utilisation.

48. Important Corrections to the Original Notes

The term:

“Renal failure”

is better replaced with:

AKI or CKD, depending on the situation.

The statement:

“Potassium-sparing diuretics reduce tubular creatinine secretion”

is too broad.

The classic high-yield drug association is:

TRIMETHOPRIM OR CIMETIDINE → REDUCED TUBULAR CREATININE SECRETION → MODEST CREATININE RISE WITHOUT TRUE GFR FALL.

SIADH is much more strongly associated with:

LOW UREA

than with low creatinine.

Diuretics usually raise urea indirectly because they can cause:

VOLUME DEPLETION AND PRE-RENAL HYPOPERFUSION.

Alcohol misuse generally lowers urea indirectly through:

MALNUTRITION, LOW PROTEIN INTAKE OR LIVER DISEASE.

Key Clinical Pattern

Remember:

↑ CREATININE → THINK REDUCED GFR FIRST.

Also consider:

LARGE MUSCLE MASS + RHABDOMYOLYSIS + TRIMETHOPRIM/CIMETIDINE.

↓ CREATININE → THINK LOW MUSCLE MASS OR PREGNANCY.

↑ UREA → THINK REDUCED GFR + DEHYDRATION + UPPER GI BLEED + HIGH PROTEIN + CATABOLISM.

↓ UREA → THINK LIVER DISEASE + LOW PROTEIN INTAKE + SIADH + PREGNANCY.

And the most useful overall distinction is:

CREATININE = MORE INFLUENCED BY GFR AND MUSCLE MASS.

UREA = MORE INFLUENCED BY GFR, HYDRATION, PROTEIN METABOLISM AND LIVER FUNCTION.